CN108524814A - A kind of Chinese medicine composition and preparation method thereof for reducing blood glucose - Google Patents
A kind of Chinese medicine composition and preparation method thereof for reducing blood glucose Download PDFInfo
- Publication number
- CN108524814A CN108524814A CN201810456193.XA CN201810456193A CN108524814A CN 108524814 A CN108524814 A CN 108524814A CN 201810456193 A CN201810456193 A CN 201810456193A CN 108524814 A CN108524814 A CN 108524814A
- Authority
- CN
- China
- Prior art keywords
- parts
- extract
- powder mixture
- blood glucose
- coarse powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 130
- 239000008280 blood Substances 0.000 title claims abstract description 130
- 239000000203 mixture Substances 0.000 title claims abstract description 95
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title claims abstract description 94
- 239000008103 glucose Substances 0.000 title claims abstract description 91
- 239000003814 drug Substances 0.000 title claims abstract description 57
- 230000001603 reducing effect Effects 0.000 title claims abstract description 41
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 239000000284 extract Substances 0.000 claims abstract description 248
- 230000000694 effects Effects 0.000 claims abstract description 89
- 230000002218 hypoglycaemic effect Effects 0.000 claims abstract description 59
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 42
- 235000016425 Arthrospira platensis Nutrition 0.000 claims abstract description 27
- 240000002900 Arthrospira platensis Species 0.000 claims abstract description 27
- 229940082787 spirulina Drugs 0.000 claims abstract description 27
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 18
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 18
- 235000008434 ginseng Nutrition 0.000 claims abstract description 18
- 229940107666 astragalus root Drugs 0.000 claims abstract description 12
- 239000000843 powder Substances 0.000 claims description 72
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 41
- 241000508269 Psidium Species 0.000 claims description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 241000124033 Salix Species 0.000 claims description 24
- 238000000605 extraction Methods 0.000 claims description 24
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 22
- 238000000855 fermentation Methods 0.000 claims description 21
- 230000004151 fermentation Effects 0.000 claims description 21
- 235000008422 Schisandra chinensis Nutrition 0.000 claims description 20
- 240000006079 Schisandra chinensis Species 0.000 claims description 20
- 235000002991 Coptis groenlandica Nutrition 0.000 claims description 17
- 244000247747 Coptis groenlandica Species 0.000 claims description 17
- 240000004371 Panax ginseng Species 0.000 claims description 17
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 17
- 239000011701 zinc Substances 0.000 claims description 17
- 229910052725 zinc Inorganic materials 0.000 claims description 17
- 244000046146 Pueraria lobata Species 0.000 claims description 16
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 16
- 240000005528 Arctium lappa Species 0.000 claims description 15
- 235000003130 Arctium lappa Nutrition 0.000 claims description 15
- 240000008042 Zea mays Species 0.000 claims description 15
- 240000002234 Allium sativum Species 0.000 claims description 14
- 235000008078 Arctium minus Nutrition 0.000 claims description 14
- 235000004611 garlic Nutrition 0.000 claims description 14
- 235000008708 Morus alba Nutrition 0.000 claims description 13
- 240000000249 Morus alba Species 0.000 claims description 13
- 244000025254 Cannabis sativa Species 0.000 claims description 12
- 235000017276 Salvia Nutrition 0.000 claims description 12
- 239000008517 radix Trichosanthis Substances 0.000 claims description 12
- 150000003384 small molecules Chemical class 0.000 claims description 12
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 11
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 11
- 235000021511 Cinnamomum cassia Nutrition 0.000 claims description 11
- 235000007244 Zea mays Nutrition 0.000 claims description 11
- 229940089639 cornsilk Drugs 0.000 claims description 11
- 235000019359 magnesium stearate Nutrition 0.000 claims description 11
- 210000000582 semen Anatomy 0.000 claims description 11
- 239000000126 substance Substances 0.000 claims description 11
- 239000001231 zea mays silk Substances 0.000 claims description 11
- 241000893536 Epimedium Species 0.000 claims description 9
- 239000002775 capsule Substances 0.000 claims description 9
- 235000018905 epimedium Nutrition 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- 244000302512 Momordica charantia Species 0.000 claims description 6
- 235000009811 Momordica charantia Nutrition 0.000 claims description 6
- 235000009812 Momordica cochinchinensis Nutrition 0.000 claims description 6
- 235000018365 Momordica dioica Nutrition 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 235000019640 taste Nutrition 0.000 claims description 6
- 108010059892 Cellulase Proteins 0.000 claims description 5
- 229940106157 cellulase Drugs 0.000 claims description 5
- 238000000746 purification Methods 0.000 claims description 5
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 3
- 235000005822 corn Nutrition 0.000 claims description 3
- 238000001704 evaporation Methods 0.000 claims description 3
- 230000008020 evaporation Effects 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 229910052573 porcelain Inorganic materials 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 230000002269 spontaneous effect Effects 0.000 claims description 3
- 244000077995 Coix lacryma jobi Species 0.000 claims description 2
- 240000007164 Salvia officinalis Species 0.000 claims 2
- 238000000034 method Methods 0.000 abstract description 20
- 239000011573 trace mineral Substances 0.000 abstract description 13
- 235000013619 trace mineral Nutrition 0.000 abstract description 13
- 238000012360 testing method Methods 0.000 abstract description 12
- 230000000144 pharmacologic effect Effects 0.000 abstract description 11
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract description 8
- 235000010755 mineral Nutrition 0.000 abstract description 8
- 239000011707 mineral Substances 0.000 abstract description 8
- 239000008194 pharmaceutical composition Substances 0.000 abstract description 8
- 239000002994 raw material Substances 0.000 abstract description 6
- 230000003750 conditioning effect Effects 0.000 abstract description 5
- 229940126678 chinese medicines Drugs 0.000 abstract description 2
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000020765 fenugreek extract Nutrition 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 description 66
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 44
- 238000011282 treatment Methods 0.000 description 43
- 239000011651 chromium Substances 0.000 description 32
- 230000006870 function Effects 0.000 description 32
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 30
- 235000000346 sugar Nutrition 0.000 description 28
- 239000011669 selenium Substances 0.000 description 25
- 108090001061 Insulin Proteins 0.000 description 23
- 230000036772 blood pressure Effects 0.000 description 23
- 102000004877 Insulin Human genes 0.000 description 22
- 229940125396 insulin Drugs 0.000 description 22
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 21
- 229910052804 chromium Inorganic materials 0.000 description 21
- 239000000463 material Substances 0.000 description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 17
- 229940079593 drug Drugs 0.000 description 17
- 239000003925 fat Substances 0.000 description 17
- 235000019197 fats Nutrition 0.000 description 17
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 16
- 235000013399 edible fruits Nutrition 0.000 description 16
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 15
- 201000010099 disease Diseases 0.000 description 15
- 229910052711 selenium Inorganic materials 0.000 description 15
- 150000003626 triacylglycerols Chemical class 0.000 description 15
- 241000605447 Anemarrhena Species 0.000 description 14
- 229930191283 anemarrhena Natural products 0.000 description 14
- 235000012000 cholesterol Nutrition 0.000 description 14
- 241000411851 herbal medicine Species 0.000 description 14
- 201000001421 hyperglycemia Diseases 0.000 description 14
- 210000002700 urine Anatomy 0.000 description 14
- 239000004615 ingredient Substances 0.000 description 13
- 210000004185 liver Anatomy 0.000 description 13
- 210000000496 pancreas Anatomy 0.000 description 13
- 238000011160 research Methods 0.000 description 13
- 230000008859 change Effects 0.000 description 12
- 150000004676 glycans Chemical class 0.000 description 12
- 230000036541 health Effects 0.000 description 12
- 229920001282 polysaccharide Polymers 0.000 description 12
- 239000005017 polysaccharide Substances 0.000 description 12
- 230000008569 process Effects 0.000 description 12
- 230000001737 promoting effect Effects 0.000 description 12
- 210000002966 serum Anatomy 0.000 description 12
- 235000015468 Lycium chinense Nutrition 0.000 description 11
- 210000002216 heart Anatomy 0.000 description 11
- 210000003734 kidney Anatomy 0.000 description 11
- 150000002632 lipids Chemical class 0.000 description 11
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 10
- 241001072909 Salvia Species 0.000 description 10
- 230000001976 improved effect Effects 0.000 description 10
- 230000009467 reduction Effects 0.000 description 10
- 108010023302 HDL Cholesterol Proteins 0.000 description 9
- 206010022489 Insulin Resistance Diseases 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 230000004060 metabolic process Effects 0.000 description 9
- 150000003254 radicals Chemical class 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 241000196324 Embryophyta Species 0.000 description 8
- 244000241872 Lycium chinense Species 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 230000002829 reductive effect Effects 0.000 description 8
- 230000001225 therapeutic effect Effects 0.000 description 8
- 230000035922 thirst Effects 0.000 description 8
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 7
- 208000004880 Polyuria Diseases 0.000 description 7
- 229930003268 Vitamin C Natural products 0.000 description 7
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 7
- 230000035619 diuresis Effects 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 235000016709 nutrition Nutrition 0.000 description 7
- -1 oxygen ion Chemical class 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 238000010791 quenching Methods 0.000 description 7
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 7
- 235000019154 vitamin C Nutrition 0.000 description 7
- 239000011718 vitamin C Substances 0.000 description 7
- 241001061264 Astragalus Species 0.000 description 6
- 241000522254 Cassia Species 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 6
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 6
- 230000003712 anti-aging effect Effects 0.000 description 6
- 235000006533 astragalus Nutrition 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 210000002421 cell wall Anatomy 0.000 description 6
- 239000000470 constituent Substances 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 230000003914 insulin secretion Effects 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 210000004233 talus Anatomy 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 244000241838 Lycium barbarum Species 0.000 description 5
- 235000015459 Lycium barbarum Nutrition 0.000 description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 241000218989 Trichosanthes Species 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 230000001093 anti-cancer Effects 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 210000004204 blood vessel Anatomy 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 230000002708 enhancing effect Effects 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 229910052742 iron Inorganic materials 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 230000012666 negative regulation of transcription by glucose Effects 0.000 description 5
- 230000001151 other effect Effects 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 206010067484 Adverse reaction Diseases 0.000 description 4
- 108010088751 Albumins Proteins 0.000 description 4
- 102000009027 Albumins Human genes 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 201000001320 Atherosclerosis Diseases 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 206010018473 Glycosuria Diseases 0.000 description 4
- 102000001554 Hemoglobins Human genes 0.000 description 4
- 108010054147 Hemoglobins Proteins 0.000 description 4
- 244000198896 Lagerstroemia speciosa Species 0.000 description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 4
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 4
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 230000006838 adverse reaction Effects 0.000 description 4
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 239000000496 cardiotonic agent Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 229930003944 flavone Natural products 0.000 description 4
- 150000002213 flavones Chemical class 0.000 description 4
- 235000011949 flavones Nutrition 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 208000019622 heart disease Diseases 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 230000003834 intracellular effect Effects 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- 229910052749 magnesium Inorganic materials 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 230000004224 protection Effects 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 229940116269 uric acid Drugs 0.000 description 4
- 238000002562 urinalysis Methods 0.000 description 4
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical group CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 3
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 241000195493 Cryptophyta Species 0.000 description 3
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 3
- 208000002249 Diabetes Complications Diseases 0.000 description 3
- 206010012655 Diabetic complications Diseases 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 102000003746 Insulin Receptor Human genes 0.000 description 3
- 108010001127 Insulin Receptor Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- 108010053210 Phycocyanin Proteins 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 229930182558 Sterol Natural products 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 description 3
- 235000010081 allicin Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000003178 anti-diabetic effect Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 230000000840 anti-viral effect Effects 0.000 description 3
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 239000003472 antidiabetic agent Substances 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 3
- 230000023852 carbohydrate metabolic process Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 229930002875 chlorophyll Natural products 0.000 description 3
- 235000019804 chlorophyll Nutrition 0.000 description 3
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 3
- 208000029078 coronary artery disease Diseases 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- WQLVFSAGQJTQCK-UHFFFAOYSA-N diosgenin Natural products CC1C(C2(CCC3C4(C)CCC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 WQLVFSAGQJTQCK-UHFFFAOYSA-N 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 230000009931 harmful effect Effects 0.000 description 3
- 235000008216 herbs Nutrition 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 201000001881 impotence Diseases 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 230000002608 insulinlike Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 230000002045 lasting effect Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 230000000116 mitigating effect Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 235000021251 pulses Nutrition 0.000 description 3
- 102000005962 receptors Human genes 0.000 description 3
- 108020003175 receptors Proteins 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 150000003432 sterols Chemical class 0.000 description 3
- 235000003702 sterols Nutrition 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 102100031126 6-phosphogluconolactonase Human genes 0.000 description 2
- 108010029731 6-phosphogluconolactonase Proteins 0.000 description 2
- 101710186708 Agglutinin Proteins 0.000 description 2
- 102000004506 Blood Proteins Human genes 0.000 description 2
- 108010017384 Blood Proteins Proteins 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 241000208368 Euonymus alatus Species 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 229920000926 Galactomannan Polymers 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 208000002705 Glucose Intolerance Diseases 0.000 description 2
- 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 2
- 101710146024 Horcolin Proteins 0.000 description 2
- 239000009636 Huang Qi Substances 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 208000013016 Hypoglycemia Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 101710189395 Lectin Proteins 0.000 description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 2
- 241000219991 Lythraceae Species 0.000 description 2
- 101710179758 Mannose-specific lectin Proteins 0.000 description 2
- 101710150763 Mannose-specific lectin 1 Proteins 0.000 description 2
- 101710150745 Mannose-specific lectin 2 Proteins 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- WWNNZCOKKKDOPX-UHFFFAOYSA-N N-methylnicotinate Chemical compound C[N+]1=CC=CC(C([O-])=O)=C1 WWNNZCOKKKDOPX-UHFFFAOYSA-N 0.000 description 2
- 206010029164 Nephrotic syndrome Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 241000205407 Polygonum Species 0.000 description 2
- 206010060862 Prostate cancer Diseases 0.000 description 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 2
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 2
- 235000014360 Punica granatum Nutrition 0.000 description 2
- 241000405414 Rehmannia Species 0.000 description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- WQLVFSAGQJTQCK-CAKNJAFZSA-N Yamogenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@H](C)CO1 WQLVFSAGQJTQCK-CAKNJAFZSA-N 0.000 description 2
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 230000001133 acceleration Effects 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000000910 agglutinin Substances 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000000702 anti-platelet effect Effects 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000013734 beta-carotene Nutrition 0.000 description 2
- 239000011648 beta-carotene Substances 0.000 description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 2
- 229960002747 betacarotene Drugs 0.000 description 2
- 238000004820 blood count Methods 0.000 description 2
- 210000002798 bone marrow cell Anatomy 0.000 description 2
- 239000002368 cardiac glycoside Substances 0.000 description 2
- 229940097217 cardiac glycoside Drugs 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 230000002279 cholagogic effect Effects 0.000 description 2
- 150000001841 cholesterols Chemical class 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- 229940109239 creatinine Drugs 0.000 description 2
- 239000000287 crude extract Substances 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 238000010410 dusting Methods 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 235000006694 eating habits Nutrition 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 210000001508 eye Anatomy 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000002594 fluoroscopy Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 206010017758 gastric cancer Diseases 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 230000006377 glucose transport Effects 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 230000002607 hemopoietic effect Effects 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000003345 hyperglycaemic effect Effects 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 230000004130 lipolysis Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 201000005202 lung cancer Diseases 0.000 description 2
- 208000020816 lung neoplasm Diseases 0.000 description 2
- 235000012661 lycopene Nutrition 0.000 description 2
- 229960004999 lycopene Drugs 0.000 description 2
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 2
- 239000001751 lycopene Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 208000009928 nephrosis Diseases 0.000 description 2
- 231100001027 nephrosis Toxicity 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- LPMXVESGRSUGHW-HBYQJFLCSA-N ouabain Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1C[C@@]2(O)CC[C@H]3[C@@]4(O)CC[C@H](C=5COC(=O)C=5)[C@@]4(C)C[C@@H](O)[C@@H]3[C@@]2(CO)[C@H](O)C1 LPMXVESGRSUGHW-HBYQJFLCSA-N 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 201000009104 prediabetes syndrome Diseases 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 229930002534 steroid glycoside Natural products 0.000 description 2
- 150000005856 steroid saponins Chemical class 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 201000011549 stomach cancer Diseases 0.000 description 2
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 2
- 150000003648 triterpenes Chemical class 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 229940096998 ursolic acid Drugs 0.000 description 2
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 description 1
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- NNMALANKTSRILL-ZUTFDUMMSA-N 3-[(2z,5z)-2-[[3-(2-carboxyethyl)-5-[(z)-[(3z,4r)-3-ethylidene-4-methyl-5-oxopyrrolidin-2-ylidene]methyl]-4-methyl-1h-pyrrol-2-yl]methylidene]-5-[(4-ethyl-3-methyl-5-oxopyrrol-2-yl)methylidene]-4-methylpyrrol-3-yl]propanoic acid Chemical compound O=C1C(CC)=C(C)C(\C=C/2C(=C(CCC(O)=O)C(=C/C3=C(C(C)=C(\C=C/4\C(\[C@@H](C)C(=O)N\4)=C/C)N3)CCC(O)=O)/N\2)C)=N1 NNMALANKTSRILL-ZUTFDUMMSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 239000000275 Adrenocorticotropic Hormone Substances 0.000 description 1
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 241001495180 Arthrospira Species 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 241000432824 Asparagus densiflorus Species 0.000 description 1
- SMDOOINVMJSDPS-UHFFFAOYSA-N Astragaloside Natural products C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)OC2C(C(OC3C(C(O)C(O)C(CO)O3)O)C(O)C(CO)O2)O)=C1 SMDOOINVMJSDPS-UHFFFAOYSA-N 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 108010080705 Ca(2+) Mg(2+)-ATPase Proteins 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 241000208365 Celastraceae Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 101800000414 Corticotropin Proteins 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 206010066786 Diabetic keratopathy Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000055850 Diospyros virginiana Species 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 206010013700 Drug hypersensitivity Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- FWCXELAAYFYCSR-UHFFFAOYSA-N Episamogenin Natural products CC1C(C2(CCC3C4(C)CC(O)C(O)CC4CCC3C2C2)C)C2OC11CCC(C)CO1 FWCXELAAYFYCSR-UHFFFAOYSA-N 0.000 description 1
- 208000007530 Essential hypertension Diseases 0.000 description 1
- 208000007241 Experimental Diabetes Mellitus Diseases 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 102000018711 Facilitative Glucose Transport Proteins Human genes 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 101710196208 Fibrinolytic enzyme Proteins 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 108010058643 Fungal Proteins Proteins 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- FWCXELAAYFYCSR-RYKNUXCGSA-N Gitogenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)C[C@@H](O)[C@H](O)C[C@@H]4CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 FWCXELAAYFYCSR-RYKNUXCGSA-N 0.000 description 1
- ZVWCWPUAQHAINU-UHFFFAOYSA-N Gitogenin Natural products CC1CCC2(CC3OC4C5CCC6CC(O)C(O)CC6(C)C5CCC4(C)C3C2C)OC1 ZVWCWPUAQHAINU-UHFFFAOYSA-N 0.000 description 1
- 108091052347 Glucose transporter family Proteins 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 1
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 108010001483 Glycogen Synthase Proteins 0.000 description 1
- 241001530884 Gynura segetum Species 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010019851 Hepatotoxicity Diseases 0.000 description 1
- 206010020638 Hyperglycaemic conditions Diseases 0.000 description 1
- 206010060378 Hyperinsulinaemia Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 206010061523 Lip and/or oral cavity cancer Diseases 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 235000015463 Lycium carolinianum Nutrition 0.000 description 1
- 235000005079 Malus baccata Nutrition 0.000 description 1
- 244000134336 Malus baccata Species 0.000 description 1
- 206010027146 Melanoderma Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 208000009525 Myocarditis Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 208000031662 Noncommunicable disease Diseases 0.000 description 1
- 102000011931 Nucleoproteins Human genes 0.000 description 1
- 108010061100 Nucleoproteins Proteins 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- INPDFIMLLXXDOQ-UHFFFAOYSA-N Phycocyanobilin Natural products CCC1=C(C)C(=CC2=NC(=C/c3[nH]c(C=C/4C(C(C(N4)=O)C)=CC)c(C)c3CCC(=O)O)C(=C2C)CCC(=O)O)NC1=O INPDFIMLLXXDOQ-UHFFFAOYSA-N 0.000 description 1
- 240000007509 Phytolacca dioica Species 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- 102100027467 Pro-opiomelanocortin Human genes 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- GMBQZIIUCVWOCD-WWASVFFGSA-N Sarsapogenine Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)C[C@H]4CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@H](C)CO1 GMBQZIIUCVWOCD-WWASVFFGSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 235000000485 Smilax china Nutrition 0.000 description 1
- 244000261559 Smilax china Species 0.000 description 1
- 235000003205 Smilax rotundifolia Nutrition 0.000 description 1
- 240000009022 Smilax rotundifolia Species 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010049447 Tachyarrhythmia Diseases 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- RTMWIZOXNKJHRE-UHFFFAOYSA-N Tigogenin Natural products CC1COC2CC(C)(OC12)C3CCC4C5CCC6CC(O)CCC6(C)C5CCC34C RTMWIZOXNKJHRE-UHFFFAOYSA-N 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 244000078912 Trichosanthes cucumerina Species 0.000 description 1
- 108010021119 Trichosanthin Proteins 0.000 description 1
- DWCSNWXARWMZTG-UHFFFAOYSA-N Trigonegenin A Natural products CC1C(C2(CCC3C4(C)CCC(O)C=C4CCC3C2C2)C)C2OC11CCC(C)CO1 DWCSNWXARWMZTG-UHFFFAOYSA-N 0.000 description 1
- 102000001742 Tumor Suppressor Proteins Human genes 0.000 description 1
- 108010040002 Tumor Suppressor Proteins Proteins 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000012876 acute enteritis Diseases 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 238000002266 amputation Methods 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940127003 anti-diabetic drug Drugs 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000003243 anti-lipolytic effect Effects 0.000 description 1
- 230000002019 anti-mutation Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000003035 anti-peroxidant effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- QMNWISYXSJWHRY-XWJCTJPOSA-N astragaloside Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)C4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)CC3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-XWJCTJPOSA-N 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000003809 bile pigment Substances 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 230000005961 cardioprotection Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- AMSCMASJCYVAIF-QCVMBYIASA-N carpaine Chemical compound O([C@H]1CC[C@@H](CCCCCCCC(=O)O2)N[C@H]1C)C(=O)CCCCCCC[C@H]1N[C@@H](C)[C@@H]2CC1 AMSCMASJCYVAIF-QCVMBYIASA-N 0.000 description 1
- HXFUVYFNBRBBPM-UHFFFAOYSA-N carpaine Natural products CC1(CCCCCCCC(=O)O1)C2CCCN2 HXFUVYFNBRBBPM-UHFFFAOYSA-N 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000021735 chronic enteritis Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 229940108928 copper Drugs 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000003218 coronary vasodilator agent Substances 0.000 description 1
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 1
- 229960000258 corticotropin Drugs 0.000 description 1
- MDZKJHQSJHYOHJ-UHFFFAOYSA-N crataegolic acid Natural products C1C(O)C(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MDZKJHQSJHYOHJ-UHFFFAOYSA-N 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 235000019503 curry powder Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- WQLVFSAGQJTQCK-VKROHFNGSA-N diosgenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 WQLVFSAGQJTQCK-VKROHFNGSA-N 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000007323 disproportionation reaction Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000007783 downstream signaling Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 201000005311 drug allergy Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000000918 epididymis Anatomy 0.000 description 1
- 201000010063 epididymitis Diseases 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 235000013410 fast food Nutrition 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- DFNZYFAJQPLJFI-UHFFFAOYSA-N gentianine Chemical compound O=C1OCCC2=C1C=NC=C2C=C DFNZYFAJQPLJFI-UHFFFAOYSA-N 0.000 description 1
- 230000004110 gluconeogenesis Effects 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 206010019692 hepatic necrosis Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- 230000007686 hepatotoxicity Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 230000003451 hyperinsulinaemic effect Effects 0.000 description 1
- 201000008980 hyperinsulinism Diseases 0.000 description 1
- 230000003516 hyperlipidaemic effect Effects 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000005934 immune activation Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010832 independent-sample T-test Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000002473 insulinotropic effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 230000003212 lipotrophic effect Effects 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 231100000149 liver necrosis Toxicity 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 210000002189 macula lutea Anatomy 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 230000008176 mammary development Effects 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- MDZKJHQSJHYOHJ-LLICELPBSA-N maslinic acid Chemical compound C1[C@@H](O)[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MDZKJHQSJHYOHJ-LLICELPBSA-N 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000003680 myocardial damage Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000010016 myocardial function Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 208000020717 oral cavity carcinoma Diseases 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 238000007427 paired t-test Methods 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 108010072011 phycocyanobilin Proteins 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000003726 plant lectin Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000003161 proteinsynthetic effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 210000005084 renal tissue Anatomy 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- NWMIYTWHUDFRPL-UHFFFAOYSA-N sapogenin Natural products COC(=O)C1(CO)C(O)CCC2(C)C1CCC3(C)C2CC=C4C5C(C)(O)C(C)CCC5(CCC34C)C(=O)O NWMIYTWHUDFRPL-UHFFFAOYSA-N 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 229930193195 schizandrin Natural products 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 201000008525 senile cataract Diseases 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 230000020509 sex determination Effects 0.000 description 1
- 230000035946 sexual desire Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000003724 spirulina extract Nutrition 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229960001052 streptozocin Drugs 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 208000023516 stroke disease Diseases 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000037317 transdermal delivery Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 239000009685 tusanqi Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 235000020795 whole food diet Nutrition 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- YEFOAORQXAOVJQ-UHFFFAOYSA-N wuweizischun A Natural products C1C(C)C(C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/748—Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/37—Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8964—Anemarrhena
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Diabetes (AREA)
- Inorganic Chemistry (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of Chinese medicine composition and preparation method thereof for reducing blood glucose, which is made of the following raw material:4 kinds of mineral matter elements such as 6 kinds of Chinese medicines and Cr-enriched yeast such as 24 kinds of extracts such as Ba Naba extracts, fenugreek extract, Astragalus Root P.E, mulberry-leaf extract and ginseng, spirulina.After the essential trace elements of the human body is added in pharmaceutical composition of the present invention, any type clinically acceptable Suitable pharmaceutical preparations are prepared into according to this field conventional formulation method.It is good hypoglycemic that Pharmacological test results show that pharmaceutical composition of the present invention has the function of, preparation method science is simple, without any side effects, is suitble to all age group crowd, while conditioning engine body reduces blood glucose, has good effect for reducing blood fat.
Description
Technical field
More particularly, to a kind of with hypoglycemic effect, the Chinese medicine composition of control diabetic complication and its preparation side
Method belongs to medicine, food, field of health care products.
Background technology
Hyperglycemia refers to that the blood glucose of people is higher than normal level, equal to each section of human body if this situation persistently exists
It is harmful.There are many reason of causing hyperglycemia, diabetes be by inherent cause, immunologic function disorder, microorganism infection and its toxin,
The effects that free radical toxin, mental element, leads to hypoinsulinism, insulin resistance etc. and sugar, the albumen of initiation in body
A series of metabolism disturbance syndromes such as matter, fat, water and electrolyte.But with the continuous improvement of modern life level, mostly
Number factor is often that bad life habits and environment, present young man are mostly delithted with fast food, does not like vegetables and fruit, long
Long eating habit may lead to high blood glucose;In addition, with the pollution of environment, negative oxygen ion content in air is caused to reduce sharply,
The negative oxygen ion of human intake is insufficient, this is also a major reason for leading to hyperglycemia.
The clinical manifestation of diabetes is hyperglycemia and glycosuria.There is more foods, more drinks, diuresis, dry and general weakness in patient
Etc. symptoms, belong to the scope that Chinese medicine is quenched one's thirst.Diabetes and cancer, cardiovascular and cerebrovascular disease is same is considered as worldwide three big diseases.
The world today, with the acceleration of rapid development of economy and process of industrialization, human health faces non-infectious disease
The threat of disease is increasingly being, and diabetes prevalence and diabetic's quantity steeply rise.Diabetes and its complication are to people
Class health and social development bring serious burden.
The pathogenic process of diabetes complexity makes the method that the mankind not yet find radical cure so far, this means that patient needs end
Body receives treatment, but regrettably, even in developed country, also has about 2/3 patient that cannot effectively manage.Long-term blood glucose
Control bad diabetic occur together various complication the life and quality of life of patient are threatened it is very big, to family and
Patient individual brings heavy financial burden.
It is counted according to International Diabetes Federation, has a diabetic 3.31 hundred million in the whole world in 2016, and current patient of diabetes
Person, according to current growth rate, estimates that the year two thousand thirty whole world will have 600,000,000 people to suffer from diabetes up to 3.85 hundred million.According to world health
Tissue discloses, and the whole world just has 1 people to die of diabetes for every 10 seconds, just has within every 30 seconds 1 people because of diabetes amputation, blinds in addition, heart and brain
The complication such as blood vessel, diabetes have become serious public health problem.Diabetes endanger human life's safety, thus cause
Psychological problems, social concern also becomes increasingly conspicuous.Therefore, relevant expert points out, " diabetes are no longer that diabetic individual asks
Topic, even more a global problem.”
Hypoglycemic medicine is clinically still based on Western medicine at present, but because that there are hypoglycemia and gastrointestinal reactions etc. is many bad anti-for it
It answers, therefore the target for finding high-efficiency low-toxicity reduction hypoglycemic medicament is urgently realized.
Recent study find, Chinese medicine hypoglycemic effect is mildly lasting, and adverse reaction is few, the mechanism of action have manifold effect,
Multidigit point and it is multi-functional the features such as, sugar tolerance and the occurrence and development that diabetic complication is effectively relieved can be improved, be develop drop
One new approach of blood glucose new drug.
TCM Treatment of Diabetes has thousands of years of history, recorded in medical book a large amount for the treatment of diabetes Chinese medicine and its
Compound preparation, thus from Chinese traditional herbs research and develop Novel antidiabetic Chinese medicine preparation have great importance with it is wide
Foreground.Currently, being flooded with all kinds of hypoglycemic products in the market, but the seldom of real effect can be played, therefore provided a kind of
The drug that hypoglycemic effect can really be played is critically important.
There is the present invention pharmaceutical composition of effect of lowering blood sugar extracted from a variety of natural plants rich in hypoglycemic control blood glucose
Active ingredient, the research to hyperglycaemic conditions mechanism and its principle of reatment based on traditional Chinese medicine, at the same according to pharmaceutical research at
Fruit controls blood glucose from source, meets international newest healthy trend.
The present invention has the function of the pharmaceutical composition composition formula of effect of lowering blood sugar with more hypoglycemic, control blood glucose, hyperglycemia
Crowd is used for a long time its control hypoglycemic effect and becomes apparent from, and hypoglycemic effect is more reliable.
The present invention has the pharmaceutical composition of hypoglycemic effect, belongs to the Chinese medical extract of integration of drinking and medicinal herbs, secondary without any poison
Effect can adjust blood sugar level steadily, reduce hyperglycemia, and low hyperglycemia will not be caused to react, and be suitble to patient of diabetes
Person takes for a long time, not will produce dependence and drug resistance.
Invention content
The purpose of the present invention is to solve deficiencies existing for above-mentioned technical problem, provide a kind of for reducing in blood glucose
Drug composition and preparation method thereof, the composition have drawn from extensive common Chinese material or its extract, and add micro
Element adjusts the acid-base balance of human body, improves the immunity of human body, to reach reduction blood glucose, in the medical history for reducing blood glucose
It is upper to become new breakthrough point.
The Ultramicro-powder and 4 kinds of micro members of the present invention innovatively extract of the pure natural Chinese herbal medicine of 24 tastes, 6 kinds of Chinese herbal medicines
Element carries out ideally organic assembling, is equipped with advanced technological process, using up to standard selected, cleaning, purification, tanning extraction, dusting
After synthesis, with new technologies such as dry, wet fermentation, Ultramicro-powder, vibration of ultrasonic wave, reach in conjunction with scientific compatibility naturally, environmental protection, peace
Entirely, the effective purpose of health.
In view of the above-mentioned deficiencies in the prior art, it is an object of the present invention to provide a kind of pharmaceutical composition with hypoglycemic effect
Object;It is a further object to provide the preparation methods of the pharmaceutical composition.
To achieve the goals above, the present invention is to realize by the following technical solutions:
A kind of Chinese medicine composition for reducing blood pressure includes the substance of following parts by weight:
60-100 parts of banaba leaf extract, 60-100 parts of faenum graecum seed extract, 60-100 parts of money willow extract, hypoglycemic grass
60-100 parts of extract, 60-100 parts of guava leaf extract, 30-60 parts of garlic P.E, 60-130 parts of burdock extract,
40-90 parts of Corn silk P.E, 30-90 parts of Shorthorned Epimedium P.E, 60-120 parts of Astragalus Root P.E, Cortex Lycii extract 30-60
Part, 30-60 parts of mulberry bark extract, 60-120 parts of mulberry-leaf extract, 30-60 parts of Fructus lycii P.E, kudzu root extract 30-60
Part, 60-120 parts of Bitter Melon P.E, 60-120 parts of cinnamomum cassia extract, 20-30 parts of Salvia root P.E, 30-60 parts of Rhizoma Polygonati extract,
20-40 parts of Semen Coicis extract, 60-100 parts of Radix Trichosanthis extract, 30-60 parts of Rhizoma Polygonati Odorati extract, cornel extractive 60-120
Part, 30-60 parts of anemarrhena asphodefoides extract;30-80 parts of ginseng, 60-100 parts of spirulina, 60-100 parts of Ramulus euonymi, 15-45 parts of the coptis, life
20-40 parts of glutinous rehmannia, 30-60 parts of Schisandra chinensis;2-6 parts of Cr-enriched yeast, 2-4 parts of Se-enriched yeast, 1-3 parts of Zinc-rich saccharomyces cerevisiae, magnesium stearate
2-6 parts.
The present invention's this is for reducing the Chinese medicine composition preparation method of blood pressure:
Step 1: by 30-80 parts of ginseng, 60-100 parts of spirulina, 60-100 parts of Ramulus euonymi, 15-45 parts of the coptis, radix rehmanniae recen 20-
40 parts, 30-60 parts of Schisandra chinensis, cleaning selected with single product, air-dry purification, are respectively crushed into coarse powder, the granularity of coarse powder is 24-50
Mesh is uniformly mixed, it is spare that coarse powder mixture is made;It is divided into three parts;
Step 2: first part of coarse powder mixture is put into sealing porcelain, temperature is under 25-30 degree, spontaneous fermentation 5-7 days, fermentation
After the completion, it is cleaned and is dried with clear water, obtain dry fermentation coarse powder mixture;Second part of coarse powder mixture is eluted with pure water,
The cellulase of the 2-5% of second part of coarse powder total weight of the mixture is added, carries out vibration of ultrasonic wave 20-30 minutes, is sufficiently stirred,
Then fermentation being sealed to coarse powder mixture, temperature is fermented 1-3 days under 25-30 degree, after fermentation, 6-8 times clear of progress
It washes, squeeze, dry, obtain wet fermentation coarse powder mixture;Third part coarse powder mixture carries out naturally dry;First part, second
Part and third part mixture are mixed, and mixing coarse powder mixture is obtained;Mixing coarse powder mixture is ground, ultra micro is obtained
Powder mixture, the granularity of ultra micro powder mixture is at 0.1 μm -10 μm;
It is impregnated 60 minutes Step 3: small molecule energy water is added in the ultra micro powder mixture that step 2 is obtained, is made to impregnate and mix
Material is closed, wherein the weight for the small molecule energy water being added and ginseng, spirulina, Ramulus euonymi, the coptis, radix rehmanniae recen, Schisandra chinensis coarse powder
The ratio between total weight of mixture is 6:1;
Step 4: the mixture that step 3 obtains is placed in Multifunctional Chinese medicine extraction kettle, open multi-functional extraction kettle power supply into
Row is heated to 100 DEG C, keep at this temperature constant temperature lift 1 hour, produce the first extraction mixture, then filter, obtain the
No. one time extracting solution is spare;
Step 5: small molecule energy water, the weight of the weight and coarse powder mixture of the small molecule energy water of addition are added into filter residue
The ratio between amount is 2:1, heating extraction, heating temperature is 100 DEG C, and extraction time is 1 hour, and second of extracting solution is obtained by filtration;
Step 6: the merging of extracting solution twice is placed in triple effect vacuum high energy evaporation concentrator, be decompressed to relative pressure be-
0.07MPa is heated to 80 DEG C, and extracting solution is condensed into the medicinal extract that proportion is 1.30, is then dried, obtains at 45-50 DEG C
To dry extract;
Step 7: after dry extract is broken into 100-150 targeted fine powders, 60-100 parts of banaba leaf extract, faenum graecum is added
60-100 parts of seed extract, 60-100 parts of money willow extract, 60-100 parts of hypoglycemic grass extract, guava leaf extract 60-
100 parts, 30-60 parts of garlic P.E, 60-130 parts of burdock extract, 40-90 parts of Corn silk P.E, Shorthorned Epimedium P.E
30-90 parts, 60-120 parts of Astragalus Root P.E, 30-60 parts of Cortex Lycii extract, 30-60 parts of mulberry bark extract, mulberry-leaf extract
60-120 parts, 30-60 parts of Fructus lycii P.E, 30-60 parts of kudzu root extract, 60-120 parts of Bitter Melon P.E, cinnamomum cassia extract
60-120 parts, 20-30 parts of Salvia root P.E, 30-60 parts of Rhizoma Polygonati extract, 20-40 parts of Semen Coicis extract, Radix Trichosanthis extract
60-100 parts, 30-60 parts of Rhizoma Polygonati Odorati extract, 60-120 parts of cornel extractive, 30-60 parts of anemarrhena asphodefoides extract;It adds chromium-rich
2-6 parts of yeast, 2-4 parts of Se-enriched yeast, 1-3 parts of Zinc-rich saccharomyces cerevisiae, 2-6 parts of magnesium stearate are packed into gelatin hard after mixing
Capsule to get:The present invention of every 0.45 gram of weight.
Number is parts by weight in wherein all steps.
The unavailable tap water of the useful water of present composition institute, mineral water, distilled water use, and process is all using small
Molecular energy water.
Wherein in the present composition is pure natural plant extract, no incompatibility.
Wherein in step 1, the granularity of coarse powder is 24-50 mesh, cannot be too thin, can not be too thick, is in order to subsequently dry, wet
The technique of fermentation, medicinal ingredient that can utmostly in extraction of substance.
After first part of coarse powder mixture dry fermentation wherein in step 2, it can be maximally maintained Chinese medicine nutritional ingredient,
And the alcoholic degree of final products can be improved.
Second part of coarse powder mixture wherein in step 2, which impregnates, carries out vibration of ultrasonic wave 20-30 minutes, is in order to will be thick
The cell wall of powder mixture is broken, it is allowed to discharge the gamma aminobutyric acid of cell interior and the pure grade substances of plant.
The cellulase of the 2-5% of overstriking powder mixture total weight wherein in step 2 is in order to which cellulase can be broken
The structure of coarse powder mixture cell wall, destroys the structure of cell wall, and intracellular ingredient is made to dissolve, to reach the mesh of extraction
's.
The granularity of this 4 taste Chinese herbal ultra-fine powder mixture after being ground wherein in step 2 is at 0.1 μm -10 μm, due to people
This 6 taste Chinese medicine of ginseng, spirulina, Ramulus euonymi, the coptis, radix rehmanniae recen, Schisandra chinensis is hard in heterogeneity, and general be crushed can not break completely
The cell wall of this 6 taste Chinese medicine, because the dissolution of effective medicinal component needs guiding through several or even dozens of cell wall in cell, and
And quite a few Cell Component can not possibly pass through cell wall, this part that can only waste, therefore can not make intracellular
Active ingredient all fully release, the present invention reaches Ultramicro-powder by way of grinding, makes intracellular effective
Ingredient all fully releases, to improve the bioavilability of medicinal material, and this Chinese medicine mixed-powder granularity after grinding
It is very tiny, it is more advantageous to human body and drug is absorbed and utilized.
Extraction twice has been carried out to mixture in step 4 and five, has been more preferably more to extract medical substance.
Dry extract is broken into 100-150 targeted fine powders wherein in step 7, is because fine powder has reached ultra micro
Powder is not only conducive to the absorption of human body, and whole drug effects in the present invention is made to bring into play, and, the mouthfeel of user can be improved, no
Feel the pain of medication.
The present invention select banaba leaf extract, faenum graecum seed extract, money willow extract, hypoglycemic grass extract, kind
Pomegranate leaf extract, garlic P.E, burdock extract, Corn silk P.E, Shorthorned Epimedium P.E, Astragalus Root P.E,
Bone bark extract, mulberry bark extract, mulberry-leaf extract, wolfberry fruit extract, kudzu root extract, Bitter Melon P.E, Chinese cassia tree extraction
Object, Rhizoma Polygonati extract, Semen Coicis extract, Radix Trichosanthis extract, Rhizoma Polygonati Odorati extract, cornel extractive, is known Salvia root P.E
6 kinds of Chinese herbal medicines and the richness such as 24 kinds of extracts such as female extract and ginseng, spirulina, Ramulus euonymi, the coptis, radix rehmanniae recen, Schisandra chinensis
The mineral trace element combination needed by human of 4 kinds of selenium yeast, Cr-enriched yeast, Zinc-rich saccharomyces cerevisiae, magnesium stearate etc. is prepared, respectively
Active constituent in kind drug generates synergistic effect, mutually promotes improvement insulin secretion, increases insulin sensitivity, influence pancreas
Island element receptor promotes the approach such as absorption and the decomposition of glycogen of glucose to play reduction blood glucose, control blood glucose, reduce complication
Effect is repaired the vital organs of the human body, balanced human's negative and positive, is changed in addition under the common participation effect of supplement human body mineral matter trace element
Kind metabolism in vivo, filling liver kidney is deficiency of the spleen-yin, to reach the effect for the treatment of diabetes.Formula uniqueness, obvious effect, according to diabetes
The pathogenesis of people carries out specific aim adjusting, systemic conditioning, and help combines, and having significantly reduces blood glucose and control blood glucose
Effect.It is the specific short of the treatment diabetes of a new generation that the present invention, which has the pharmaceutical composition of hypoglycemic effect,.
The present composition is using technology with banaba leaf extract, faenum graecum seed extract, money willow extract, hypoglycemic
Careless extract, guava leaf extract, garlic P.E, burdock extract, Corn silk P.E, Shorthorned Epimedium P.E, Huang
Stilbene extract, Cortex Lycii extract, mulberry bark extract, mulberry-leaf extract, wolfberry fruit extract, kudzu root extract, balsam pear extraction
Object, cinnamomum cassia extract, Salvia root P.E, Rhizoma Polygonati extract, Semen Coicis extract, Radix Trichosanthis extract, Rhizoma Polygonati Odorati extract, mountain Zhu
24 kinds of Chinese herbal medicine extracts such as cornel extract, anemarrhena asphodefoides extract and ginseng, spirulina, Ramulus euonymi, the coptis, radix rehmanniae recen, Schisandra chinensis
Deng 6 kinds of Chinese herbal medicines with advanced technological process, using up to standard selected, cleaning, purification, tanning extraction, after dusting synthesis, with hair
4 kinds of trace element combination scientific compatibilities such as ferment new technology addition Cr-enriched yeast, Se-enriched yeast, Zinc-rich saccharomyces cerevisiae and magnesium stearate reach
Naturally, environmentally friendly, safety, the effective purpose of health.
Present composition formula is unique, obvious effect, the pathogenesis of foundation diabetes patient, the adjusting of progress specific aim,
Systematicness conditioning, help combine, and hypoglycemic effect will significantly open the door of health to diabetic, are combined with scientific compatibility existing
Generationization medicine has thoroughly broken hyperglycemia and has belonged to lifelong disease and can not cure, the mythology of rehabilitation.With its safety, surely
Qualitative, generality, validity have brought Gospel, due contribution are made that for the healthy cause of the mankind, in medical row
Its unique effect is played in industry.
The present invention is innovatively micro the extract of the pure natural Chinese herbal medicine of 24 tastes, the Ultramicro-powder of 6 kinds of Chinese herbal medicines and 4 kinds
Element carries out ideally organic assembling, and according to the characteristic of these three components, is divided into three kinds of different preparation methods, further according to this
The performance of medicinal ingredient contained by three groups of raw material, extracts medicinal ingredient with differently method respectively, in treatment diabetes
Meanwhile it also functioning to liver protection, protecting kidney, the healthcare functions such as enrich blood;The present invention is not only at low cost, simple for process, without side-effects, Ke Yichang
Phase takes, and reaches nature hypoglycemic, steady sugar, repairs pancreas islet, activation insulin secretion function, can gradually be withdrawn using the present invention
Western medicine reduces the toxic side effect of Western medicine, effectively controls the injection of insulin dosage.
The application method and explanation of the present invention
[primary raw material] banaba leaf extract, faenum graecum seed extract, money willow extract, hypoglycemic grass extract, kind stone
Pomegranate leaf extract, garlic P.E, burdock extract, Corn silk P.E, Shorthorned Epimedium P.E, Astragalus Root P.E, bone
Bark extract, mulberry bark extract, mulberry-leaf extract, wolfberry fruit extract, kudzu root extract, Bitter Melon P.E, cinnamomum cassia extract,
Salvia root P.E, Rhizoma Polygonati extract, Semen Coicis extract, Radix Trichosanthis extract, Rhizoma Polygonati Odorati extract, cornel extractive, burdock
Seed extract, anemarrhena asphodefoides extract are primary raw material and ginseng, spirulina, Ramulus euonymi, the coptis, radix rehmanniae recen, Schisandra chinensis and minerals
Micro- Cr-enriched yeast, Se-enriched yeast, Zinc-rich saccharomyces cerevisiae, magnesium stearate.
[primary efficacy] adjusts blood glucose, adjusts blood fat, prevents complication.
[suitable population] hyperglycemia, hyperlipemic patients take the patient of hypoglycemic Western medicine for a long time.
[instructions of taking and dosage] 0.5g capsules, three times per day, one time 2-3, warm water delivery service.
[points for attention] pregnant woman forbids taking, and forbids edible maror during medication and drinks.
The suitable crowd of the present invention
1. taking a variety of hypoglycemic medicines, the patient of long-term persistent high blood sugar.
2. refusing the patients with NIDDM of insulin therapy.
The diabetic of drink more than 3., more foods, diuresis and weight loss.
4. having generated insulin resistance, blood glucose is unstable, there is apparent complications.
5. refusing the patient of Western medicine toxic side effect treatment.
Six big advantages of the advantageous effect of the technology of the present invention during hypoglycemic
One, good effect, cure mechanism science, clear, treating both manifestation and root cause of disease.
1. can quick and stable blood glucose, it is quick.
2. diabetic complication can be improved, improve the quality of life of diabetic.
3. not only supplementing " insulin gene ", but also repair and create regeneration islet cells, ensures fundamentally rehabilitation.
Two, steady hypoglycemic while adjusting blood fat, protecting blood vessel and heart and brain organ simultaneously for recovery of melituria.
Three, prescription science, raw material is natural, has no toxic side effect.
Pancreas islet Vitality Source is the pure natural preparation for collecting gene biological technical ability and plant extracts, and bioactivity is common hypoglycemic
Ten times or more of product.Pancreas islet Vitality Source is without any side effects according to clinical verification, not the impariment of the liver, kidney, and diabetic can put
The heart is taken for a long time.
Four, high-end dosage form, it is rapid-action, effect is good.
Present composition dosage form is advanced, high in technological content.Take rear easy disintegrating, rapid-action, good absorbing.It is substantially better than biography
The formula of system.
Five, diabetic does not have to lifelong medication.
The extraction of active ingredient height, the hyperconcetration of the present composition, breach stimulation and discomfort of the previous capsule to stomach
Reaction, and broken the shortcomings of Chinese traditional herbs dosage is big, absorption is few, it is ensured that human body fully absorbing and utilizing to drug.
The treatment phase of drug has been greatly shortened, has achieved the purpose that short-term rehabilitation is discontinued.
The invention has the advantages that
1. 24 kinds of Chinese herbal medicine extracts of the composition selection of the present invention, Chinese herbal medicine material its extract for having drawn from common, no
It sticks to tradition and produces Chang Fang, the different pathogeny interpretation of the cause, onset and process of an illness of hyperglycemia is directed to using pure natural Chinese herbal medicine extract, has broken clinic
In conventional treatments, it is rapid-action, absorb thorough, significant effect, reduce side effect, conditioning viscera, Yin Yang balancing is comprehensive to adjust
Manage diabetes.
2. the composition of the present invention is mutually acted synergistically using the active constituent of 24 kinds of Chinese herbal medicine extracts, mutually increase work(
Effect matches mineral trace element chromium needed by human, selenium, zinc, magnesium, formula uniqueness, obvious effect, the hair according to diabetes patient
Anttdisease Mechanism carries out specific aim adjusting, systematicness conditioning, and help combines, and has apparent blood sugar reducing function.
3. the composition compatibility of the present invention is made a general survey of, full side, proportioning is proper, hangs together, and both improves human metabolism function,
The resistance of insulin is enhanced, and promotes the digestion, absorption, transportation capabilities of liver and spleen and stomach and intestine, reaches the work for reducing blood glucose
With.
4. prepared by the present invention has the composition for reducing blood glucose effect, to hyperglycemia the effect of notable, total effective rate reaches
It is the specific short of the wholistic therapy diabetes of a new generation to 96% or more.
1. banaba leaf extract:Lagerstroemia speciosa (Linn.) Pers. Extract is called it is observed that various plants extract is thin to ehrlich ascites cancer
It is found after the effect of born of the same parents' intake mouth glucose, banaba is one of the plant for promoting intake.Therefrom be separated to laughable Soviet Union's acid and
Two kinds of triterpene compounds of maslinic acid, the former is the promotion object of glucose transport, therefore has hypoglycemic activity.Banaba
Extract promotes absorption and utilization of the cell to glucose, to realize its effect of lowering blood sugar by the transhipment of excited glucose.
Lagerstroemia speciosa (Linn.) Pers. Extract is similar to insulin to the excitation of glucose transport, and therefore, Lagerstroemia speciosa (Linn.) Pers. Extract is also referred to as
Glucokinin.Clinical research discovery can adjust internal insulin and blood-sugar content after taking the drug, have and significantly subtract
Fertile trend, the process are relatively more slow and without diet.Lagerstroemia speciosa (Linn.) Pers. Extract total triterpene can very significantly improve diabetic
Glucose tolerance, reduce the blood glucose of diabetic, glucose in urine and saccharification hemalbumin, have hypoglycemic effect to diabetic.
2. faenum graecum seed extract:Its primary efficacy has, and has mitigation climacteric syndrome, treatment constipation, dysentery, digestion are not
It is good, diabetes are controlled, cholesterol is reduced, releive sore throat and cough promote mammary development and the effects that pregnancy period milk production.From Gu
To 19 th century laters, faenum graecum, using a key player is above played, is one of foremost chest enlarge draft in the whole world in herbal medicine.
Modern scientific research confirms that faenum graecum can also reduce cholesterol, control and treatment diabetes and climacteric syndrome.In India,
It is mixed into curry powder.India traditional herbal medicines scholar is just one of the prescription for exciting breast milk it.
The main component of faenum graecum seed has the alkaloids such as erythricine, carpaine, choline, trigonelline, sapogenin master
If diosgenin, Yamogenin and a small amount of gitogenin, trace Tigogenin.Still isolate Polygonum Bi elements or different Polygonum
The Arabic glucoside of careless element, two glucoside of glucose rhamnose of flavones, the flavonoids such as cyanidenon.General group of seed becomes:
Moisture 10.30%, ash content 3.15%, lipase 37 .61%, total protein 16.97%, total reducing sugar 3.68%, cellulose 6.4%, hemicellulose
11.98%.Solid fatty acid 92.9%, volatile fatty acid 1.5%, not saponification ingredient 0.9% in fat oil;Lecithin 6.25% is planted
Object sterol 0.5 reveals.It is mainly linoleic acid and palmitic acid in aliphatic acid, and has a small amount of oleic acid and leukotrienes.Nucleoprotein in protein
55%.It is mainly galactomannan, also -320 microgram % containing vitamin B1 in total reducing sugar.Leaf about 43 milligrams of % containing ascorbic acid.
Herb is also rich in calcium, iron, carrotene etc..The mucus of galactomannans class contained by faenum graecum and steroid saponin have drop in ten days
Blood glucose, diuresis, anti-inflammatory isoreactivity.Clinical report, control diabetes often take daily 25g faenum graecum seeds, take 21 days, can significantly drop altogether
The blood glucose and glucose in urine content of low diabetes patient.
3. guava leaf extract:Guava Leaf itself is rich in abundant nutritional ingredient, wherein protein and Vitamin C
In addition the height of content especially also contains vitamin A, B and microelements of calcium, phosphorus, iron, potassium etc..Guava Leaf, which is also rich in, meals
Eat the nutritional ingredients such as fiber, carrotene, fat.In addition contain the nutritional ingredients such as fructose, sucrose, amino acid in Guava Leaf.①
Most of glycosurias have a significantly scarce chromium phenomenon in patient body, and micro " have containing abundant in Guava Leaf fruit and leaf
Machine chromium ", chromium are the essential trace elements of the human bodys, are played an important role in normal glycometabolism and fat metabolism.2. containing fibre
Dimension is high, can effectively drain and accumulate residue extra in the intestine.3. rich in vitamin C, iron, calcium, the minerals such as phosphorus have anti-old
Change and anti-oxidation efficacy, energy skin whitening prevent blackspot and freckle from being formed, increases skin to the resistance of ultraviolet light, be Ms
Skin of staying pale optimal selection.Body vitamin at least demand is supplemented, there is antialcoholism function to the excess person that drinks.
Efficacy effect:Guava Leaf originates in South America, the cultivation of In South China various regions.Guava Leaf both can with belt leather or
It is edible with peeling, it fresh fruit can be done eats it raw and also cook, there is the effect of astringing to arrest diarrhea, anti-inflammation hemostasia, can be used for acute and chronic
Enteritis, dysentery, the illnesss such as children's indigestion.1. strengthen immunity:Guava Leaf is best one of vitamin C sources, is contained
Measure very rich, and vitamin C is a kind of antioxidant, can enhance siberian crabapple altogether function, and protection human body is resisted disease and invaded
It attacks such as flu and influenza.2. hypoglycemic:Contain abundant trace element " Organic Chromium " in Guava Leaf fruit and leaf, chromium is human body
Required trace element plays an important role in normal glycometabolism and fat metabolism.3. anticancer:Guava Leaf with it is western red
Persimmon is equally rich in lycopene, this is a carotenoid compounds, has very strong inoxidizability, tumour can be inhibited thin
Born of the same parents are proliferated and prevent healthy cell canceration;In addition, abundant VC contents, which also contribute to human body, removes vivo oxidation free radical, reduce
Cell damage has the function of preventing colon cancer, cutaneum carcinoma, prostate cancer, gastric cancer, carcinoma of mouth, breast cancer and lung cancer.3. dropping blood
Pressure:Guava Leaf contains the potassium of a large amount, the pressure for contributing to balanced human's extracellular Na+ion to generate.Potassium ion additionally aids blood
The logical effect of liquid stream, reduces the risk of heart attack and apoplexy.5. Guava Leaf contains vitamin, as vitamin E, K, pantothenic acid,
The minerals such as vitamin B6, niacin, folic acid and copper, manganese, magnesium promote blood to be formed.Vitamin C in Guava Leaf can also promote
Body absorbs more iron, to promote hemoglobin to generate.6. anti aging effect:Because being melted into rich in antioxygen in Guava Leaf
Vitamin C and lycopene can effectively reduce detrimental effect of the free radical to skin.7. anti-inflammatory:Guava Leaf and Guava Leaf
Leaf extract has anti-inflammatory property.The edible this fruit of people for suffering from chronic ache is invaded to resist inflammation.8. protecting eye
Eyeball:The vitamin A of improving eyesight is rich in Guava Leaf, and antioxidant content has the function of that protect eyes are lacked by free radical injury,
Because antioxidant content can protect retina.Mostly edible Guava Leaf can be effectively improved eyesight, protect eyes from old age
Property macula lutea and senile cataract puzzlement.
4. money willow extract:It is called blue or green money willow extract, contains many substances, money willow polysaccharide in money willow extract
With good hypoglycemic effect, hyperglycemic patients sugar tolerance can be effectively improved.Blue or green money willow in money willow extract simultaneously
Glycosides is a kind of natural sweetener, and is non-calorific value saponins, disclosure satisfy that demand of the hyperglycemic patients to sweet taste, without aggravating
The state of an illness, while there is good effect in terms of hypoglycemic, lowering blood pressure and blood fat.Thus blue or green money willow extract/money willow carries
It is good hypoglycemic product to take object.Blue or green money willow flavones in blue or green money willow extract can effectively remove internal oxygen radical, change
Kind blood circulation, reduces cholesterol, and expansion of coronary artery prevents cardiovascular and cerebrovascular disease.1. hypoglycemic:Money willow contains rich
Rich water extract and alcohol extracting can increase vasopermeability, and expansion artery improves blood circulation, and sugared generation is adjusted to play
It thanks, reduces the purpose of blood glucose.2. reducing blood lipid:Money willow contains triterpene, flavones and polysaccharide etc., there is very strong effect for reducing blood fat,
Internal metabolism is can effectively improve, to prevent the raising of total cholesterol.3. blood pressure lowering:Money willow can restore the pancreas islet of lesion
The structure and function of cell, to increase internal peripheral organization pancreas islet receptor, thus reached the work to reduce blood pressure
With.
5. hypoglycemic grass extract:Hypoglycemic agrostology name " Radix et Rhizoma Gynurae divaricatae " is called Radix Rhodiolae, composite family gynura segetum category perennial root
Herbaceous plant.Its primary efficacy:Analgesia, hemostasis, anticoagulation, hypoglycemic, antitumor action.It has very magical health care work(
Effect, contains very abundant nutriment, such as phycocolloid element, vitamin B, amino acid, it has extraordinary effect of reducing blood sugar
Fruit, at the same it can also lowering blood pressure and blood fat, have very magical effect to the inhibition of diabetes.
6. garlic P.E:Garlic P.E is exactly allicin, and shape is faint yellow fine powder.With antibacterial, resist
Hepatotoxicity wind agitation and anti-aging and other effects.Allicin is the important component for having extensive drug effect, have activating cell, promote energy production,
The effects that increasing antibacterial and anti-virus ability, accelerating metabolism, relieve fatigue.Allicin can and other materials (carbohydrate, lipid,
Protein etc.) generation compound action is combined, it also expands blood vessel, improve sanguimotor effect.Its primary efficacy:1. preventing dynamic
Pulse atherosclerosis, cardioprotection is from invasion;2. having the function of clear pest, removing toxic substances, promoting blood circulation and removing blood stasis;3. antiviral effect;③
Reducing blood lipid, blood pressure lowering, hypoglycemic also anti-platelet aggregation;5. improving the activity of fibrinolytic enzyme, having inhibition to tumour cell and killing
The effect of going out, anti-curing oncoma;It, can be with antithrombotic 6. it can reduce Coronary Atherosclerotic Plaque;7. health care, growth promotion are made
With.In terms of garlic P.E is mainly used in sterilization, health care, growth promotion.
7. Shorthorned Epimedium P.E:Have effects that kidney-replenishing, strong muscles and bones, dispelling wind and eliminating dampness.It is mainly used for tonifying kidney and strengthening yang, controls
Treat caused by wind, cold and wetness evils, strong muscles and bones, blood pressure lowering, enhancing sexual desire.It is wet to cure mainly impotence due to deficiency of the kidney, infertile, frequent micturition, muscles and bones impotence, chill
The cards such as numbness, extremity numbness.
8. Radix Trichosanthis extract:For the root of cucurbitaceous plant snakegourd, it is a kind of clearing heat-fire class Chinese medicine, there is clearing heat-fire,
It promotes the production of body fluid to quench thirst, fall fire is moisturized, the effect of apocenosis detumescence.Mainly act on that pyreticosis is thirsty, quench one's thirst, jaundice, dryness of the lung hemoptysis, carbuncle swells etc.
Illness.The trichosanthin contained in root of Chinese trichosanthes being capable of effective antitumor, antiviral, raising body immunity.Contain in root of Chinese trichosanthes
Root of Chinese trichosanthes agglutinin be a kind of phytolectin of gala sugar specificity, have proof, root of Chinese trichosanthes agglutinin in vitro experiment
With Anti-lipolytic and promote the insulin-like effects such as Fatty synthesis, there is specific bond power, help to reduce glycosuria galactolipin
The incidence of disease.The glucose contained in root of Chinese trichosanthes, galactolipin, fructose, the polysaccharide materials such as mannose can help anticancer, improve
Immunocompetence.And radices trichosanthis polysaccharide also has hypoglycemic effect.
9. Corn silk P.E:.From the style and column cap of grass maize.Modern pharmacological studies have shown that
1. diuresis:There is diuresis to people or rabbit, chloride discharge rate can be increased, the insoluble part of aqueous extract methanol is passed through
Dialysis person's diuresis is most strong.Diuresis is mainly the outer property of kidney, very weak to the effect of kidney.2. reducing the effect of blood glucose:
The leavening of corn stigma has the reduction blood glucose of highly significant to act on rabbit.3. cholagogic, anastalsis:Corn stigma can promote
Into bile excretion, its viscosity is reduced, reduces its BILE PIGMENTS content, thus it is medicinal to can be used as cholagogic.
10. burdock extract:Can be by inhibiting a- glucosidase activities to play hypoglycemic effect, it can significantly for a long time
Reduction blood glucose, and improve to the dosis tolerata of carbohydrate.Great burdock achene is resistant to nephropathy, inhibits the work of the excretion of Urine proteins
With there is certain therapeutic effect to hyperglycemia nephrosis;In addition its energy antibacterial, antiviral, raising immunity, are easy diseases caused by external factors, burdock
Son is very useful to this.
11. Astragalus Root P.E:Pharmacological research shows that Radix Astragali has dual regulation to blood glucose, has and reinforces myocardial contraction
Power, diastole coronary vasodilator, reduces blood pressure, and protects liver cell, reduces the effect of blood glucose.Astragaloside can be by promoting pancreas islet β thin
Intracrine insulin plays hypoglycemic effect, and astragalus polyose has protective effect to the cardiac muscle of diabetes.Active constituent in Radix Astragali
Astragalus polyose can mitigate endoplasmic reticulum damage by improving the er stress of liver, increase glycogen synthase activity, increase pancreas
Island element signal protein synthetic quantity and activity, to play antidiabetic effect.Chinese herbal medicine astragalus can enhance and adjust immune response effect
It answers, there is urine detumescence, prevent or reverse Urine proteins effect, fibrosis, the hardening process of renal tissue can be delayed, to diabetogenous nephrosis
Disease progression has certain prevention effect.Astragalus in Treating diabetes recent studies have shown that astragalus polyose is that have to live compared with Johnson & Johnson's object
Property macromolecular compound, it is no matter oral or astragalus polyose is injected intraperitoneally, can significantly reduce KKAy Mouse
Weight, blood glucose and insulin resistance index, moreover it is possible to improve impaired glucose tolerance, slim the abdomen, increase insulin sensitivity,
But do not influence insulin secretion.
12. Cortex Lycii extract:Also known as boxthorn root, it is one kind of Chinese medicine, dark tan powder.With cool blood except steaming, clearing lung-heat
The effect of fall fire.Root bark of Chinese wolf-berry decoction gives rabbit gavage, first makes the raising of blood glucose short time, then persistently reduces, and reduces within 4-5 hours
It is most apparent, 14% is averagely reduced, is maintained 4-8 hours, it is oral to tissue of experimental diabetic mice pancreas then to restore normal root bark of Chinese wolf-berry decoction
The morphosis damage of island B cell also has certain mitigation to act on.The root bark of Chinese wolf-berry is to mouse glucose and adrenal gland disposition hyperglycemia
There is significant hypoglycemic effect..Pharmaceutical research shows that the root bark of Chinese wolf-berry has the function of apparent blood pressure lowering and hypoglycemic.
13. mulberry bark extract, mulberry-leaf extract:Hypoglycemic effect research to the drug of 50 kinds of traditional treatment diabetes
Show there is significantly reducing blood glucose, especially it is the most apparent to reduce blood glucose effect for the root bark of white mulberry.Pharmacological research proves,
Mulberry leaf have the function of that inhibition blood glucose rises, and can prevent and treat diabetes to a certain extent.With reduction blood glucose, reduce blood
Pressure reduces the various health care functions such as blood fat, anti-aging.
14. Fructus lycii P.E:With immunological regulation, hypoglycemic, reducing blood lipid and other effects.Modern analysis shows the fruit of Chinese wolfberry
Contained nutritional ingredient is very abundant, also contain the multiple elements such as abundant potassium, sodium, calcium, magnesium, zinc and 24 kinds of amino acid and
Multivitamin.Active ingredient is polysaccharides.There is kidney-supplementing liver-boosting, controls the deficiency of liver-yin and kidney-yin, quench one's thirst and other effects.With reduction blood
Sugar reduces blood pressure and lipotropic effect.The decline that Fructus lycii P.E can promote diabetes glucose lasting, to diabetic
Blood glucose, blood fat increase, and dysphotia has improvement result.Modern pharmacological studies have shown that the fruit of Chinese wolfberry is not only full of nutrition but also certain
With various health functions.It is carried out with isolated sterling (pure fraction) polysaccharides (LBP-1,2,3,4)
Function assessment evaluation experimental further demonstrates that:Polysaccharides is strictly the important function factor that the fruit of Chinese wolfberry has many pharmacological actions
One of.
15. kudzu root extract:It is the main component of isoflavones in legume pueraria lobata root dry root.Through its multipath, more
The mild action of target spot is sticked and is assembled in clinical antiplatelet, and Hemorheology state is improved, and expansion artery blood vessel adjusts blood
Fat, it is hypoglycemic etc. to embody curative effect that is unique and determining.Pueraria lobata can reduce the blood of alloxan and streptozotocin rat
Sugar and glycosylated hemoglobin, improve serum insulin level, and Puerarin can also enhance sensibility of the histocyte to insulin.Pueraria lobota
Root can block contraction of the receptor,β to blood vessel, expand blood vessel, mitigate the effect of confrontation insulinotropic hormones, improve
Insulin sensitivity.Microcirculation can also be improved, reduce whole blood viscosity, improve cell calcium-magnesium-ATPase activity, promoted
Sugar entering and insulin transdermal delivery.Flavones in kudzu root extract can increase brain and coronal vascular flow, and vascular resistence reduces, tool
It has antihypertensive effect, Puerarin can be such that blood glucose is decreased obviously, and hypoglycemic effect is lasting.
16. Bitter Melon P.E:Pharmacological research shows that balsam pear crude extract tool is significantly reduced blood glucose effect.Radiation is exempted from
Epidemic disease method, which measures Bitter Melon P.E and insulin receptor, insulin antibody, apparent association reaction, shows that it is known as with pancreas islet
Common antigenicity and bioactivity.Therefore balsam pear crude extract has the function of similar insulin.On the one hand balsam pear inhibits sugar different
Raw key enzyme generates blood sugar reducing function, on the other hand reinforces grape by activating the glucose-6-phosphate dehydrogenase (G6PD) of alternative pathway
The oxidation of sugar utilizes.Balsam pear can not only promote glucose tolerance in mice and insulin tolerance, but also can also adjust insulin receptor phosphorus
Acidification level and its downstream signaling molecule, so as to improve body insulin resistance.
17. cinnamomum cassia extract:Modern pharmacological studies have shown that Chinese cassia tree can reduce the blood glucose of diabetic.Take high dose
The average blood glucose levels of Chinese cassia tree drop to 8.0 from 8.9, and the average blood glucose levels for taking low dosage Chinese cassia tree drop to 8.2 from 8.9,
The blood glucose for not taking in Chinese cassia tree does not change.Chinese cassia tree reduces the pharmacological mechanism of blood glucose effect mainly by protection, stimulation pancreas islet β
Cell and the content for increasing serum insulin;Increase the sensibility of insulin, improves insulin resistance ability, contribute to internal Portugal
The metabolism of grape sugar;Remove free radical, anti peroxidation of lipid;Promote insulin secretion, increases the content of serum insulin.
18. Salvia root P.E:There are promoting blood circulation, promoting circulation of blood, cool blood, blood-nourishing, it can stagnation resolvation, dredging collateral.Radix Salviae Miltiorrhizae decoction can be apparent
Reduction blood glucose, as long as retaining potency for 5 hours, and blood fat and blood viscosity can be reduced.
19. Rhizoma Polygonati extract:With 1. bacteriostatic and disease prevention.Sealwort can play the effect of certain antibacterial and antibacterial action,
And some illnesss caused by dermatophyte can also be alleviated.In addition to this, additionally it is possible to reinforce myocardial function, prevent
The illness of cardiovascular aspect occurs.2. hypoglycemic.Modern medical studies have confirmed that sealwort contains clayey liquid, starch, carbohydrate, Tianmen
Winter propylhomoserin, cardiac glycoside etc. can reduce blood pressure, coronary blood flow made to increased, and can inhibit glucose in urine and blood glucose, especially pair
Blood glucose caused by adrenaline is excessively high apparent inhibiting effect.3. nourishing Yin and moistening lung.Sealwort has the effect of good nourishing Yin and moistening lung
Fruit, while can also achieve the effect that promote the production of body fluid to quench thirst, kidney-tonifying health-care, can also it play the role of for benefiting the spleen for nourishing blood good.4, sealwort
Also have the effect of blood pressure lowering, hypoglycemic, reducing blood lipid, be equally also prevented from atherosclerosis, reach anti-aging and resists
The effect of bacterium, sealwort also have the function of immune activation.
20. Semen Coicis extract:In fine brownish-yellow powder, be tonifying lung invigorating the spleen, promoting urination and removing dampness food and medicament dual-purpose product, be
Splendid beauty food materials, especially contained proteolytic enzyme can be such that skin keratin softens, and vitamin E has antioxygen to be turned into
With.Modern pharmacological research shows that coix seed has the function of reducing blood glucose, is particularly suitable for obese diabetic with hypertension
Person.
21. Rhizoma Polygonati Odorati extract:With nourishing yin to moisten dryness, QI invigorating nourishing the stomach, heat-clearing, promote the production of body fluid to quench thirst and other effects.As tonic,
Cure mainly the diseases such as consumption of YIN caused by febrile disease, abnormal heat cough caused by dryness, heart disease, diabetes.It is mainly used for promoting the production of body fluid to quench thirst, drops internal heat, reducing blood lipid, cardiac stimulant shield
The heart, anti-aging.
22. cornel extractive:The alcohol extracting thing of Fructus Corni is not only to alloxan and epinephrine glycosuria disease rat
There is the apparent blood glucose that reduces to act on, and be formed by diabetes rat to streptozotocin (STZ) also to have similar effect, but right
Normal rat blood glucose has no significant effect.Experiment shows:Fructus Corni pulvis, ether extract and the equal energy of ursolic acid further detached
Blood glucose, glucose in urine, amount of drinking water and urine volume are significantly reduced, illustrates that ursolic acid is the active constituent of Fructus Corni anti-diabetic, there is report
Announcement is pointed out, is tested with rat epididymis adipose tissue and is found that Fructus Corni has insulin-like effects, Fructus Corni tannic acid that can inhibit lipid mistake
Oxidation prevents lipolysis, and adrenaline and adrenocorticotropic hormone can also be inhibited to promote the effect of lipolysis.Fructus Corni
With tonifying the liver and kidney, puckery essence prevent prolapse.For dizziness and tinnitus, soreness of waist and knee joint, impotence and seminal emission, profuse sweating collapse, Heat Diabetes.
23. anemarrhena asphodefoides extract:The rhizome of Liliaceae herbaceos perennial rhizoma anemarrhenae is mainly extracted, appearance is brown color essence
Fine powder.The active ingredient of anemarrhena asphodefoides extract includes containing a variety of steroid saponins, mucilaginous substance, niacin.Its primary efficacy:Heat-clearing is rushed down
Fire, enriching yin cough caused by dryness, quench one's thirst, hectic fever due to yin labor heat, the diseases such as insomnia.Rhizoma anemarrhenae water logging extract, can reduce the blood glucose level of normal rabbit, especially
It is more notable to the effect of alloxan diabetes rabbit.The application field of anemarrhena asphodefoides extract:1. anemarrhena asphodefoides extract is as sterilization
The application of agent.2. application and anemarrhena asphodefoides extract of the anemarrhena asphodefoides extract in preparing improvement insulin resistance drug are preparing prevention
Application in tachyarrhythmia and essential hypertension drug.
24. ginseng:It is for example weak, thirsty, empty that pharmacological research shows that ginseng treatment diabetes can not only improve general symptom
It is weak etc., and blood glucose and glucose in urine can be reduced.Suitable for it is light-duty, diabetes mellitus type.Differential diagnosis in tcm kidney deficiency, gas deficiency of Yin person curative effect are more
Good, the scorching person of the deficiency of Yin should not take.
25. spirulina extract:Spirulina, also known as " arthrospira ", are grown in various fresh water and seawater.Spirulina is rich in
The substances such as chlorophyll, phycocyanobilin, creatine have the toxic side effect reaction for mitigating cancer radiation, chemotherapy, improve immune function, drop
Low blood fat and other effects.1. adjusting blood glucose:It, can be by a variety of there are a variety of sugar reducing substances such as spirulina polysaccharide, magnesium, chromium in spirulina
Approach (such as promote insulin secretion, slow down sugar absorption, promote metabolism, is anti-oxidant) adjusts metabolism of blood glucose.2. reducing courage
Sterol:Cholesterol reduces the breaking-out that can effectively prevent heart disease and stroke disease, and the Y- leukotrienes in spirulina can drop
Cholesterol contained by low human body lowers cholesterol so as to effectively reduce blood pressure and prevent heart disease.3. treating anemia:Spiral shell
It revolves and contains abundant active iron, vitamin B12 and chlorophyll in algae, they are the raw material and coenzyme of synthesis hemoglobin, and
Phycocyanin, polysaccharides in spirulina can enhance polychromatic erythrocyte and the ratio for just incarnadining cell in mouse bone marrow cells, therefore
Spirulina can promote hemoglobin synthesis and hemopoietic function of bone marrow from many aspects, play the effect of anti-anemia action.3. antifatigue:Freely
Base is one of the root of human senility and disease, and superoxide dismutase (S0D) can be reacted with catalytic disproportionation removes free radical.Spiral shell
Rotation algae can mitigate oxygen free radical injury caused by movement, protect membrane structure, have anti-sports fatigue to act on.5. protecting intestines
Stomach:Most of patients with gastric disease belongs to hyperhydrochloria, leads to the diseases such as gastritis, gastric ulcer, and spirulina is basic food, is inside contained
Very high vegetable protein and abundant chlorophyll, beta carotene etc., these nutrients neutralize hydrochloric acid in gastric juice and gastrointestinal tract is viscous
Film reparation, regeneration and normal secretions function are extremely effective, especially suitable for stomach patient.6. enhancing immune system:Due to spiral
Polysaccharides and phycocyanin in algae can enhance the proliferation activity of bone marrow cell, promote the life of the immune organs such as thymus gland, spleen
Biosynthesis that is long and promoting haemocyanin, therefore spirulina has immunological enhancement.7. anti-cancer tumor suppressor:Anti- mutation and anticancer
The mechanism of action of drug is related with the reparation of DNA (DNA), polysaccharides, beta carotene, phycocyanin in spirulina
There is this effect, therefore spirulina shows important function in terms of antitumor, anti-cancer.
26. Ramulus euonymi:For the branch or aliform adjunct of the tool fin of Celastraceae plant winged euonymus, have blood-breaking promoting menstruation,
The effect of removing toxicity for detumescence, desinsection, hypoglycemic, cardiac stimulant.Blood sugar reducing function Oxaloacetic sodium ingredient contained by Ramulus euonymi, can promote pancreas
Insulin secretion is reinforced in beta cell hyperplasia, a- cellular atrophies, thus plays the role of reducing blood glucose.It is raised in Ramulus euonymi decoction
Oxaloacetic sodium ingredient has blood sugar reducing function.Clinic Ramulus euonymi 30g, is equal with chinaroot greenbrier, raw pueraria lobata and uses, to mild diabetes,
Or blood glucose maintains light, moderate increasing state after taking antidiabetic drug, adds with after these Chinese medicines, Chinese and Western medicine is used in combination, and can heighten the effect of a treatment, blood
Sugar can decline at leisure, until normal range (NR).Winged euonymus cardiac glycoside contained by Ramulus euonymi has cardiac stimulant and coronary dilatation effect, Ji Nengzhi
It connects and acts on cardiac muscle cell, play cardiac effect, and make coronary artery dilator and peripheral vessels play effect promoting blood circulation and removing blood stasis, it is right
The heart diseases myocardial damages such as coronary heart disease, high heart, myocarditis have auxiliary therapeutic action.
27. the coptis:According to clinical report, coptis treatment diabetes can be such that blood glucose significantly reduces.Experiment shows berberine
Hypoglycemic mechanism has no effect on the secretion and release of insulin, nor affects on the number and affinity of Hepatocyte Insulin, and
It is to generate blood sugar reducing function by inhibiting gluconeogenesis and promoting glycolysis.
28. radix rehmanniae recen:There is nourishing Yin and clearing heat.Blood glucose can be made significantly to decline, also can inhibit and prevent adrenaline
Caused blood glucose rises, and can improve the hyperlipidemia of diabetic keratopathy, the hyperglycemia state of an illness.Clinical application is when diabetes, mostly with life
Glutinous rehmannia is with asparagus fern, fruit of Chinese wolfberry etc..
29. Schisandra chinensis:Its fruit contains schizandrin and vitamin C, resin, tannin and a small amount of carbohydrate, can enhance and be immunized, prolongs
Seminal emission is controlled in slow aging;It also can gentle palmic rate and alleviation hypertension.1. Schisandra chinensis is that effect is distinguished, unisex yin-nourishing
One of controlling nocturnal emission with astringent drugs tonic.2. liver protecting:Schisandra chinensis can promote the detoxification processes of liver, protect liver from poisoning, and can regenerate
The impaired liver organization because of abuse of alcohol, drug or hepatitis.3. shield heart cardiac stimulant:It can generate protective effect to heart tissue,
It also can gentle palmic rate and alleviation hypertension.3. anti-anti- free radical infringement:Free radical be cause atherosclerosis, cancer,
Coronary heart disease and immune hypodynamic main cause, and cause the arch-criminal of ageing process acceleration.Wood contained by Schisandra chinensis
Phenol element is potent antioxidants, can inhibit free radical, and can increase the level of antioxidant-glutathione of liver.5. enhancing
Physical efficiency:Schisandra chinensis can enhance endurance and strength and accelerate antisecosis.6. enhancing anti-pressure ability:Schisandra chinensis is most effective plant
One of agent is adapted to, intelligence, physical efficiency and sense organ function can be promoted, and enhance the resistance to pressure.In brief, it can help people
Body bears the pressure factor of such as hot and cold, noise, mood excess load etc, thus contribute to promoted work performance, enhancing endurance and
It lessens fatigue.Also have the function of that promoting intelligence perfects, slows down aging simultaneously.
30. Cr-enriched yeast:Chromium is one of safest the essential trace elements of the human body, many to be acted on diabetes about inscription
Research shows that:Trace element chromium is in close relations with diabetes.Chromium mainly reinforces insulin function to the effect of glycometabolism.
In the tissue for relying on insulin, even if the only increase of milli trace chromium, insulin function will be improved significantly;Chromium is taken in not
Foot, body can increase the demand of insulin.Normal person's demand is 20-50 μ g/ days, and children, pregnant woman and old man are 50-
110 μ g/ days, diabetic and obese people are 50-200 μ g/ days.Chromium is nearly all trivalent in human body, in wholefood
Content it is relatively low, in the form of trivalent exist.Trivalent chromium is the central active ingredient of glucose tolerance factor.Scarce chromium is to cause sugar
The pathogeny sexual factor of urine disease, atherosclerosis.Scarce chromium can be with impaired glucose tolerance, the reduction of pancreas islet affinity, beta cell sensibility
It reduces, insulin receptor reduction, blood glucose is too high or too low.Above-mentioned exception can be corrected after mending chromium.Cr-enriched yeast can reduce
The blood glucose of diabetic can also improve its hypoglycemic reaction, have the dual regulation effect to blood glucose, can effectively control sugar
Urine disease, eliminates the abnormal phenomenon in terms of glucose tolerance.Scientists point out how to go that diabetic is instructed rationally to absorb this
Kind trace element, and be not to generate another side effect, then become a recent studies on project.And most safe, most effective side
Method is most safe using glucose tolerance factor chromium, and yeast chromium is safest at present.
31. Se-enriched yeast:It is that selenium element is added during culture yeasts, selenium has been absorbed and utilized in when yeast growth, makes
Selenium in yeast protein and polysaccharide organic combined and be converted into Biological Selenium, it is secondary anti-to the poison of human body to eliminate chemical selenium
It should be stimulated with stomach, enable that selenium is more efficient, be more safely absorbed by the body utilization.Se-enriched yeast be also so far it is domestic most
Efficiently, the most balanced selenium-replenishing preparation of most safe, nutrition.Selenium is micro- necessary to human body, and selenium can prevent and inhibit swollen
Tumor, anti-aging, the normal function for maintaining cardiovascular system, the appearance of prevention of arterial hardening and coronary heart disease.Selenium-supply can reduce liver cancer,
The incidence of gastric cancer, lung cancer, prostate cancer and the carcinoma of the rectum.Selenium is referred to as " treating liver necrosis protective factors ", is to prevent hepatonecrosis
One of factor.Selenium can stimulate the generation of immunoglobulin, and the various immune functions of human body is made to be improved.Diabetes patient's blood selenium is bright
The aobvious blood selenium less than normal person.Selenium-supply can reduce blood glucose level, while increase the activity of GPX.Selenium has insulin-like effects,
Target tissue can be promoted not increase insulin level in blood while reducing blood glucose using glucose, cell in terms of fat can be stimulated
The transport process of glucose transporter on film, this provides opportunity for the treatment of diabetes hyperinsulinemia patient.
32. Zinc-rich saccharomyces cerevisiae:Zinc is one of the essential trace elements of the human body, and the constituent as a variety of enzymes widely participates in
Various metabolic activities.In human body, zinc is the widest essential trace element of distribution, and intracellular most abundant micro member
Element.In vital movement, zinc plays " life gear " effect and DNA replication dna, the rna transcription of transhipment matter and energy metabolism
The required structural constituent of required enzyme is synthesized with nucleic acid.
Specific implementation mode
To make the technical means, the creative features, the aims and the efficiencies achieved by the present invention be easy to understand, with reference to
Specific implementation mode, the present invention is further explained.
Embodiment 1
A kind of Chinese medicine composition for reducing blood pressure includes the substance of following parts by weight:
60 parts of banaba leaf extract, 100 parts of faenum graecum seed extract, 100 parts of money willow extract, hypoglycemic grass extract 60
Part, 100 parts of guava leaf extract, 60 parts of garlic P.E, 130 parts of burdock extract, 40 parts of Corn silk P.E, excessive sheep
30 parts of leaves of pulse plants extract, 60 parts of Astragalus Root P.E, 30 parts of Cortex Lycii extract, 60 parts of mulberry bark extract, mulberry-leaf extract 120
Part, 30 parts of Fructus lycii P.E, 60 parts of kudzu root extract, 60 parts of Bitter Melon P.E, 120 parts of cinnamomum cassia extract, Salvia root P.E
20 parts, 60 parts of Rhizoma Polygonati extract, 20 parts of Semen Coicis extract, 100 parts of Radix Trichosanthis extract, 30 parts of Rhizoma Polygonati Odorati extract, Fructus Corni
120 parts of extract, 60 parts of anemarrhena asphodefoides extract, 30 parts of ginseng, 100 parts of spirulina, 60 parts of Ramulus euonymi, 45 parts of the coptis, radix rehmanniae recen 40
Part, 30 parts of Schisandra chinensis, 2 parts of Cr-enriched yeast, 2 parts of Se-enriched yeast, 1 part of Zinc-rich saccharomyces cerevisiae, 6 parts of magnesium stearate.
Embodiment 2
A kind of Chinese medicine composition for reducing blood pressure includes the material composition of following parts by weight:
100 parts of banaba leaf extract, 60 parts of faenum graecum seed extract, 100 parts of money willow extract, hypoglycemic grass extract 60
Part, 100 parts of guava leaf extract, 30 parts of garlic P.E, 130 parts of burdock extract, 90 parts of Corn silk P.E, excessive sheep
90 parts of leaves of pulse plants extract, 120 parts of Astragalus Root P.E, 60 parts of Cortex Lycii extract, 30 parts of mulberry bark extract, mulberry-leaf extract 6120
Part, 30 parts of Fructus lycii P.E, 60 parts of kudzu root extract, 120 parts of Bitter Melon P.E, 120 parts of cinnamomum cassia extract, Salvia root P.E
20 parts, 60 parts of Rhizoma Polygonati extract, 40 parts of Semen Coicis extract, 100 parts of Radix Trichosanthis extract, 60 parts of Rhizoma Polygonati Odorati extract, Fructus Corni
120 parts of extract, 60 parts of anemarrhena asphodefoides extract, 80 parts of ginseng, 100 parts of spirulina, 100 parts of Ramulus euonymi, 15 parts of the coptis, radix rehmanniae recen 20
Part, 60 parts of Schisandra chinensis, 6 parts of Cr-enriched yeast, 4 parts of Se-enriched yeast, 1 part of Zinc-rich saccharomyces cerevisiae, 2 parts of magnesium stearate.
Embodiment 3
A kind of Chinese medicine composition for reducing blood pressure includes the material composition of following parts by weight:
80 parts of banaba leaf extract, 90 parts of faenum graecum seed extract, 60 parts of money willow extract, 100 parts of hypoglycemic grass extract,
70 parts of guava leaf extract, 50 parts of garlic P.E, 100 parts of burdock extract, 60 parts of Corn silk P.E, Herba Epimedii carry
Take 70 parts of object, 80 parts of Astragalus Root P.E, 40 parts of Cortex Lycii extract, 50 parts of mulberry bark extract, 80 parts of mulberry-leaf extract, matrimony vine
50 parts of seed extract, 60 parts of kudzu root extract, 110 parts of Bitter Melon P.E, 110 parts of cinnamomum cassia extract, 30 parts of Salvia root P.E, Huang
60 parts of essence extract, 40 parts of Semen Coicis extract, 80 parts of Radix Trichosanthis extract, 60 parts of Rhizoma Polygonati Odorati extract, cornel extractive 120
Part, 30 parts of anemarrhena asphodefoides extract, 50 parts of ginseng, 80 parts of spirulina, 80 parts of Ramulus euonymi, 35 parts of the coptis, 30 parts of radix rehmanniae recen, Schisandra chinensis 50
Part, 5 parts of Cr-enriched yeast, 3 parts of Se-enriched yeast, 2 parts of Zinc-rich saccharomyces cerevisiae, 4 parts of magnesium stearate.
The preparation method of above example is:
Step 1: by 30-80 parts of ginseng, 60-100 parts of spirulina, 60-100 parts of Ramulus euonymi, 15-45 parts of the coptis, radix rehmanniae recen 20-
40 parts, 30-60 parts of Schisandra chinensis, cleaning selected with single product, air-dry purification, are respectively crushed into coarse powder, the granularity of coarse powder is 24-50
Mesh is uniformly mixed, it is spare that coarse powder mixture is made;It is divided into three parts;
Step 2: first part of coarse powder mixture is put into sealing porcelain, temperature is under 25-30 degree, spontaneous fermentation 5-7 days, fermentation
After the completion, it is cleaned and is dried with clear water, obtain dry fermentation coarse powder mixture;Second part of coarse powder mixture is eluted with pure water,
The cellulase of the 2-5% of second part of coarse powder total weight of the mixture is added, carries out vibration of ultrasonic wave 20-30 minutes, is sufficiently stirred,
Then fermentation being sealed to coarse powder mixture, temperature is fermented 1-3 days under 25-30 degree, after fermentation, 6-8 times clear of progress
It washes, squeeze, dry, obtain wet fermentation coarse powder mixture;Third part coarse powder mixture carries out naturally dry;First part, second
Part and third part mixture are mixed, and mixing coarse powder mixture is obtained;Mixing coarse powder mixture is ground, ultra micro is obtained
Powder mixture, the granularity of ultra micro powder mixture is at 0.1 μm -10 μm;
It is impregnated 60 minutes Step 3: small molecule energy water is added in the ultra micro powder mixture that step 2 is obtained, is made to impregnate and mix
Material is closed, wherein the weight for the small molecule energy water being added and ginseng, spirulina, Ramulus euonymi, the coptis, radix rehmanniae recen, Schisandra chinensis coarse powder
The ratio between total weight of mixture is 6:1;
Step 4: the mixture that step 3 obtains is placed in Multifunctional Chinese medicine extraction kettle, open multi-functional extraction kettle power supply into
Row is heated to 100 DEG C, keep at this temperature constant temperature lift 1 hour, produce the first extraction mixture, then filter, obtain the
No. one time extracting solution is spare;
Step 5: small molecule energy water, the weight of the weight and coarse powder mixture of the small molecule energy water of addition are added into filter residue
The ratio between amount is 2:1, heating extraction, heating temperature is 100 DEG C, and extraction time is 1 hour, and second of extracting solution is obtained by filtration;
Step 6: the merging of extracting solution twice is placed in triple effect vacuum high energy evaporation concentrator, be decompressed to relative pressure be-
0.07MPa is heated to 80 DEG C, and extracting solution is condensed into the medicinal extract that proportion is 1.30, is then dried, obtains at 45-50 DEG C
To dry extract;
Step 7: after dry extract is broken into 100-150 targeted fine powders, 60-100 parts of banaba leaf extract, faenum graecum is added
60-100 parts of seed extract, 60-100 parts of money willow extract, 60-100 parts of hypoglycemic grass extract, guava leaf extract 60-
100 parts, 30-60 parts of garlic P.E, 60-130 parts of burdock extract, 40-90 parts of Corn silk P.E, Shorthorned Epimedium P.E
30-90 parts, 60-120 parts of Astragalus Root P.E, 30-60 parts of Cortex Lycii extract, 30-60 parts of mulberry bark extract, mulberry-leaf extract
60-120 parts, 30-60 parts of Fructus lycii P.E, 30-60 parts of kudzu root extract, 60-120 parts of Bitter Melon P.E, cinnamomum cassia extract
60-120 parts, 20-30 parts of Salvia root P.E, 30-60 parts of Rhizoma Polygonati extract, 20-40 parts of Semen Coicis extract, Radix Trichosanthis extract
60-100 parts, 30-60 parts of Rhizoma Polygonati Odorati extract, 60-120 parts of cornel extractive, 30-60 parts of anemarrhena asphodefoides extract;It adds chromium-rich
2-6 parts of yeast, 2-4 parts of Se-enriched yeast, 1-3 parts of Zinc-rich saccharomyces cerevisiae, 2-6 parts of magnesium stearate are packed into gelatin hard after mixing
Capsule to get:The present invention of every 0.45 gram of weight.
The related experimental data of hypoglycemic effect of the present invention is as follows:
1. material
1.1 sample:It is provided by central hospital of Xinxiang City, is divided into No. 1, No. 2 capsules, wherein No. 1 capsule is placebo, No. 2 capsules
For the present composition.Human oral's recommended dose is 2 times a day, 2 tablets each time.Capule size:0.5g/.
1.2 love examination person's selections
1.2.1 inclusion criteria
Subject's male or female, age 18-65 Sui.Blood sampling 2 times in half a year, 2 serum total cholesterols >=5.2mmo1/L or blood
Clear triglycerides >=1.65mmo1/L, simple dyslipidemia, without apparent brain, the heart, liver, lung, kidney, Hematological Diseases, no Long-term taking medicine
History, voluntarily tested guarantee cooperation.
1.2.2 subject excludes mark Huaihe River
Gestation or women breast-feeding their children, to drug allergy person;Merge intentionally, liver, the serious diseases patient such as kidney and hemopoietic system;In short term
Article related with tested function is inside taken, is influenced to result judgement person;Inclusion criteria is not met, it is practical not tested by regulation
Sample, can not judging effect or data, umbra does not ring effect or safe sex determination person.
2. experiment
2.1 designs and grouping
Using itself between group two kinds of control designs.It is randomly divided into capsule for treating group and comfort of the present invention by subject's blood lipid level
Agent control group considers the principal element such as age, gender, diet etc. for influencing result, carries out harmonious inspection, as far as possible to ensure
Comparativity between group.Therapeutic test is carried out by double-blind study.
2.2 experimental method
Subject takes sample by recommended dose daily, continuously takes 45 days.Original eating habit is not changed during experiment, just
Normal diet.
3. observation index
Every observation index in therapeutic test start and at the end of respectively measure it is primary.
3.1 safety indexes
3.1.1 general physical examination:The feelings such as detailed spirit, sleep, diet, stool and urine inquired and understand subject before experiment
Condition measures weight, blood pressure, changes in heart rate before and after experimenter.
3.1.2 blood routine:Red blood cell count(RBC), white blood cell count(WBC) and classification, content of hemoglobin measurement etc..
3.1.3 routine urinalysis:PH value, leucocyte, glucose in urine etc..
3.1.4 stool routine examination.
3.1.5 abdominal B-scan ultrasonography, electrocardiogram, Ⅹ line fluoroscopy of chest inspection (being measured before on-test primary).
3.1.6 blood biochemistry index inspection:Total serum protein (TP), albumin (ALB), glutamic-pyruvic transaminase (ALT), millet straw turn
The measurement such as ammonia enzyme (AST), uric acid (UA), urea nitrogen (BUN), creatinine (Cr), blood glucose (GLU).
3.1.7 adverse reaction is observed.
3.2 efficacy measures
Serum total cholesterol (CH0L), triglycerides (TG), high-density lipoprotein sterol (HDL-C).
4. result judgement
4.1CH0L reducing>10%;TG is reduced>15%;HDL-C rises>0.104mmo1/L;Each functional observation index Test is front and back certainly
Comparison among groups have statistical significance after body compares and treats, and can judge the index positive.
Two 4.2 serum total cholesterols, triglycerides index positives, high-density lipoprotein cholesterol, which is not significantly lower than, to be compareed
Group can determine that tested material has auxiliary reducing blood lipid work(effect;A positive in two serum total cholesterol, triglycerides indexs,
High-density lipoprotein cholesterol is not significantly lower than control group, can determine that there is tested material auxiliary to reduce serum total cholesterol or auxiliary
Reduce triglycerides effect.
5. statistical procedures
As a result mean ± standard deviation is used to indicate, self pair data uses paired t-test, in variance between test group and control group
Under the premise of neat, mean compares using independent samples t-test, otherwise carries out variables transformations, meets variance and uses t to examine afterwards together, if
Variance is still uneven, using rank sum test.
6. result
6.1 safety observations
6.1.1 ordinary circumstance:Treatment group 53, control group 53.Before and after treatment, curer's spirit, sleep, diet, stool and urine
Situation no abnormality seen;Control group:Male/female is 20/33, and the age is 46.74 ± 11.56 years old;Treatment group:Male/female is 20/33, year
Age is 46.72 ± 11.55.
6.1.2 abdominal B-scan ultrasonography, electrocardiogram, x-ray fluoroscopy of chest detection:In normal range (NR).
6.1.3 weight, blood pressure, heart rate, routine urinalysis, stool routine examination, routine blood indexes situation of change.
1 pretherapy and post-treatment weight of table, blood pressure, heart rate, routine urinalysis, stool routine examination and blood routine situation of change (Ⅹ ± S)
By table 1 as it can be seen that the forward and backward treatment group for the treatment of tested material and control group weight, blood pressure, heart rate, routine urinalysis, stool routine examination and blood
Conventional rule are showed no obvious abnormalities variation, illustrate the harmful effect of the invention without above-mentioned aspect.
6.1.4 blood biochemistry index situation of change before and after therapeutic test
Changes of biochemical indexes situation (X ± S) before and after 2 therapeutic test of table
As can be seen from Table 2, the forward and backward treatment group for the treatment of tested material and control group total serum protein (TP), albumin (ALB), Gu Bingzhuan
Ammonia enzyme (ALT), glutamic-oxalacetic transaminease (AST), creatinine (Cr), blood glucose (GLU), uric acid (UA), urea nitrogen (BUN) are showed no apparent different
Often variation illustrates the harmful effect of the invention without above-mentioned aspect.
6.1.5 obvious adverse reaction is had no during treating.
6.2 functional observation
Change of serum C H0L, TG, HDL-C levels (X ± S) before and after 3 therapeutic test of table
Change of serum C H0L, TG, HDL-C levels (X ± S) before and after 4 therapeutic test of table
Note:* the P ﹤ 0.05 compared with before treatment, # P ﹤ 0.05 compared with the control group.
5 pretherapy and post-treatment change of serum C H0L, TG, HDL-C situation of change of table.
It by table 3-5 as it can be seen that taking a blood sample in half a year twice, respectively treats preceding 1 and treats preceding 2 blood fat data, close taken with the date
2 blood lipid levels are grouped and statistical disposition before the treatment of tested material.Control group and treatment group's change of serum C H0L, TG are horizontal before experiment
Compare, no significant difference (P>0.05) it is comparable between, prompting two groups.After treatment group's treatment before CH0L, TG and treatment
And compare after control group treatment, difference is significant (P ﹤ 0.05).Pretherapy and post-treatment HDL-C levels are to substantially change (P>
0.05)。
7. conclusion
Using counter point between own control and group, after selecting the volunteer for meeting experimental condition to take tested material 45 days, knot
Fruit shows:CH0L, TG are compared with before treatment after taking tested material test group treatment of the present invention, the significant (P of difference<0.05),
And decline 10.21%, 20.99% more respectively before CH0L, TG and treatment after treating;After treatment before treatment group CH0L, TG and treatment
And compare after control group treatment, the significant (P of difference<0.05);After treatment treatment group HDL-C compared with the control group difference without aobvious
Work property (P>0.05).Obvious adverse reaction is had no during treatment.The above clinical study results show, it is possible to determine that the present invention combines
Object has hypoglycemic effect.
Claims (5)
1. a kind of Chinese medicine composition for reducing blood glucose, it is characterised in that:Include the substance of following parts by weight:Banaba leaf
60-100 parts of extract, 60-100 parts of faenum graecum seed extract, 60-100 parts of money willow extract, hypoglycemic grass extract 60-100
Part, 60-100 parts of guava leaf extract, 30-60 parts of garlic P.E, 60-130 parts of burdock extract, Corn silk P.E
40-90 parts, 30-90 parts of Shorthorned Epimedium P.E, 60-120 parts of Astragalus Root P.E, 30-60 parts of Cortex Lycii extract, the root bark of white mulberry extraction
30-60 parts of object, 60-120 parts of mulberry-leaf extract, 30-60 parts of Fructus lycii P.E, 30-60 parts of kudzu root extract, Bitter Melon P.E
60-120 parts, 60-120 parts of cinnamomum cassia extract, 20-30 parts of Salvia root P.E, 30-60 parts of Rhizoma Polygonati extract, Semen Coicis extract
20-40 parts, 60-100 parts of Radix Trichosanthis extract, 30-60 parts of Rhizoma Polygonati Odorati extract, 60-120 parts of cornel extractive, rhizoma anemarrhenae extraction
30-60 parts of object;30-80 parts of ginseng, 60-100 parts of spirulina, 60-100 parts of Ramulus euonymi, 15-45 parts of the coptis, radix rehmanniae recen 20-40
Part, 30-60 parts of Schisandra chinensis;2-6 parts of Cr-enriched yeast, 2-4 parts of Se-enriched yeast, 1-3 parts of Zinc-rich saccharomyces cerevisiae, 2-6 parts of magnesium stearate.
2. a kind of preparation method of Chinese medicine composition for reducing blood glucose according to claim 1, it is characterised in that:Step
Rapid one, by 30-80 parts of ginseng, 60-100 parts of spirulina, 60-100 parts of Ramulus euonymi, 15-45 parts of the coptis, 20-40 parts of radix rehmanniae recen, five
30-60 parts of taste, cleaning selected with single product, air-dry purification, are respectively crushed into coarse powder, are uniformly mixed, coarse powder mixture is made
It is spare;It is divided into three parts;Step 2: first part of coarse powder mixture is put into sealing porcelain, temperature is under 25-30 degree, spontaneous fermentation
It 5-7 days, after fermentation, is cleaned and is dried with clear water, obtain dry fermentation coarse powder mixture;Second part of coarse powder mixture pure water
It is eluted, the cellulase of the 2-5% of second part of coarse powder total weight of the mixture is added, carry out vibration of ultrasonic wave 20-30 minutes,
It is sufficiently stirred, fermentation then is sealed to coarse powder mixture, temperature is fermented 1-3 days under 25-30 degree, after fermentation, carries out 6-
8 cleanings are squeezed, and are dried, are obtained wet fermentation coarse powder mixture;Third part coarse powder mixture carries out naturally dry;First
Part, second part and third part mixture are mixed, and mixing coarse powder mixture is obtained;Mixing coarse powder mixture is ground,
Obtain ultra micro powder mixture;Step 3: small molecule energy water is added in the ultra micro powder mixture that step 2 is obtained impregnates 60 points
Clock is made and impregnates mixture, wherein the weight for the small molecule energy water being added and ginseng, spirulina, Ramulus euonymi, the coptis, Radix Rehmanniae
The ratio between yellow, Schisandra chinensis coarse powder mixture total weight is 6:1;Step 4: the mixture that step 3 obtains is placed in the more work(of Chinese medicine
It can extract in kettle, open multi-functional extraction kettle power supply and carry out being heated to 100 DEG C, constant temperature lifts 1 hour at this temperature for holding, makes
The first extraction mixture is taken, is then filtered, it is spare to obtain first time extracting solution;Step 5: small molecule energy is added into filter residue
Water, the weight of the small molecule energy water of addition are 2 with the weight ratio of coarse powder mixture:1, heating extraction, heating temperature 100
DEG C, extraction time is 1 hour, and second of extracting solution is obtained by filtration;Step 6: extracting solution merging twice is placed on triple effect vacuum
In high energy evaporation concentrator, it is -0.07MPa to be decompressed to relative pressure, is heated to 80 DEG C, and it is 1.30 that extracting solution, which is condensed into proportion,
Medicinal extract, be then dried at 45-50 DEG C, obtain dry extract;Step 7: after dry extract is broken into fine powder, addition bar
By 60-100 parts of bar leaf extract, 60-100 parts of faenum graecum seed extract, 60-100 parts of money willow extract, hypoglycemic grass extract
60-100 parts, 60-100 parts of guava leaf extract, 30-60 parts of garlic P.E, 60-130 parts of burdock extract, corn stigma
40-90 parts of extract, 30-90 parts of Shorthorned Epimedium P.E, 60-120 parts of Astragalus Root P.E, 30-60 parts of Cortex Lycii extract, Sang Bai
30-60 parts of bark extract, 60-120 parts of mulberry-leaf extract, 30-60 parts of Fructus lycii P.E, 30-60 parts of kudzu root extract, balsam pear
60-120 parts of extract, 60-120 parts of cinnamomum cassia extract, 20-30 parts of Salvia root P.E, 30-60 parts of Rhizoma Polygonati extract, coix seed
20-40 parts of extract, 30-60 parts of Rhizoma Polygonati Odorati extract, 60-120 parts of cornel extractive, is known 60-100 parts of Radix Trichosanthis extract
Female extract 30-60 parts;Add 2-6 parts of Cr-enriched yeast, 2-4 parts of Se-enriched yeast, 1-3 parts of Zinc-rich saccharomyces cerevisiae, magnesium stearate 2-6
Part, after mixing, be packed into snap fit capsule to get:The present invention of every 0.45 gram of weight.
3. a kind of preparation method of Chinese medicine composition for reducing blood glucose according to claim 2, it is characterised in that:Step
Coarse granularity in rapid one is 24-50 mesh.
4. a kind of preparation method of Chinese medicine composition for reducing blood glucose according to claim 2, it is characterised in that:Step
The granularity of ultra micro powder mixture is at 0.1 μm -10 μm in rapid two.
5. a kind of preparation method of Chinese medicine composition for reducing blood glucose according to claim 2, it is characterised in that:Step
Dry extract is broken into 100-150 targeted fine powders in rapid seven.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810456193.XA CN108524814A (en) | 2018-05-14 | 2018-05-14 | A kind of Chinese medicine composition and preparation method thereof for reducing blood glucose |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810456193.XA CN108524814A (en) | 2018-05-14 | 2018-05-14 | A kind of Chinese medicine composition and preparation method thereof for reducing blood glucose |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108524814A true CN108524814A (en) | 2018-09-14 |
Family
ID=63477432
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810456193.XA Pending CN108524814A (en) | 2018-05-14 | 2018-05-14 | A kind of Chinese medicine composition and preparation method thereof for reducing blood glucose |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108524814A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109463685A (en) * | 2018-11-22 | 2019-03-15 | 河南农业大学 | A kind of preparation method and health care product of woody hypoglycemic composition |
CN109939143A (en) * | 2019-04-22 | 2019-06-28 | 刘德平 | A kind of Chinese medicine composition and preparation method thereof for hypoglycemic control complication |
CN110624061A (en) * | 2019-10-28 | 2019-12-31 | 王守军 | Traditional Chinese medicine for treating diabetes and preparation method thereof |
CN113499366A (en) * | 2021-08-11 | 2021-10-15 | 河北御芝林生物科技有限公司 | Composition with function of reducing blood sugar and blood fat simultaneously and preparation method thereof |
CN113797244A (en) * | 2020-06-17 | 2021-12-17 | 利统股份有限公司 | Herbal composition for reducing uric acid, body fat and blood sugar and application thereof |
CN115554388A (en) * | 2022-11-03 | 2023-01-03 | 广州四季泰来生物技术有限公司 | Nutrition balance formula for improving female polycystic ovarian hormone level and production process |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101361933A (en) * | 2008-09-28 | 2009-02-11 | 李静 | Preparation method of hypoglycemic granules |
CN104771613A (en) * | 2015-03-17 | 2015-07-15 | 济南骄泰信息技术有限公司 | Traditional Chinese medicine composition capable of reducing blood sugar |
-
2018
- 2018-05-14 CN CN201810456193.XA patent/CN108524814A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101361933A (en) * | 2008-09-28 | 2009-02-11 | 李静 | Preparation method of hypoglycemic granules |
CN104771613A (en) * | 2015-03-17 | 2015-07-15 | 济南骄泰信息技术有限公司 | Traditional Chinese medicine composition capable of reducing blood sugar |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109463685A (en) * | 2018-11-22 | 2019-03-15 | 河南农业大学 | A kind of preparation method and health care product of woody hypoglycemic composition |
CN109939143A (en) * | 2019-04-22 | 2019-06-28 | 刘德平 | A kind of Chinese medicine composition and preparation method thereof for hypoglycemic control complication |
CN110624061A (en) * | 2019-10-28 | 2019-12-31 | 王守军 | Traditional Chinese medicine for treating diabetes and preparation method thereof |
CN113797244A (en) * | 2020-06-17 | 2021-12-17 | 利统股份有限公司 | Herbal composition for reducing uric acid, body fat and blood sugar and application thereof |
US20210393730A1 (en) * | 2020-06-17 | 2021-12-23 | Lytone Enterprise, Inc. | Herbal composition for reducing uric acid and the use in reducing uric acid, body fat, and blood glucose thereof |
CN113499366A (en) * | 2021-08-11 | 2021-10-15 | 河北御芝林生物科技有限公司 | Composition with function of reducing blood sugar and blood fat simultaneously and preparation method thereof |
CN113499366B (en) * | 2021-08-11 | 2022-09-30 | 河北御芝林生物科技有限公司 | Composition with function of reducing blood sugar and blood fat simultaneously and preparation method thereof |
CN115554388A (en) * | 2022-11-03 | 2023-01-03 | 广州四季泰来生物技术有限公司 | Nutrition balance formula for improving female polycystic ovarian hormone level and production process |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103719498B (en) | A kind of Siberian solomonseal rhizome health-care tea improving immunity and preparation method thereof | |
CN108524814A (en) | A kind of Chinese medicine composition and preparation method thereof for reducing blood glucose | |
CN101239112B (en) | Chinese medicinal composition for regulating blood fat and preparation thereof | |
CN102845745A (en) | Dendrobium officinale health-care product | |
CN103749822B (en) | A kind of fruit of glossy privet hypertension and hyperlipemia health protection tea and preparation method thereof | |
CN101797326A (en) | Chinese materia medica preparation for treating borborygmus diarrhoea and preparation method thereof | |
CN103734424A (en) | Tartary buckwheat tea capable of losing weight, reducing lipid and relaxing bowels, and preparation method of tea | |
CN103301413A (en) | Traditional Chinese medicine composition for treating hyperlipemia and hyperglycemia | |
CN101607051B (en) | Traditional Chinese medicine composition for losing weight and preparation method thereof | |
CN112336815A (en) | Anti-aging composition for strengthening body, preventing cancer and conditioning hypertension, hyperglycemia and hyperlipidemia and application thereof | |
CN108578544A (en) | A kind of Chinese medicine composition and the preparation method and application thereof with blood sugar reducing function | |
CN103933346A (en) | Blood-glucose-reducing composition and preparation method thereof | |
CN104223297B (en) | A kind of schisandra chinensis health-care oral liquid of slow down aging and preparation method thereof | |
CN109105587A (en) | The tea bag and preparation method thereof of effect is relieved fatigue with strengthen immunity | |
CN106215118A (en) | Antineoplastic health preparation and preparation method thereof | |
CN113209194B (en) | Composition for treating chronic gastritis and preparation method and application thereof | |
CN104984296A (en) | Pharmaceutical composition for treating female climacteric syndrome and preparation method thereof | |
CN104286864A (en) | Flatstem milkvetch seed oral liquid for improving immunity and preparation method thereof | |
CN114177261A (en) | Chinese herbal medicine formula for preventing and treating chronic diseases and resisting cancer and protecting health | |
CN105327115B (en) | A kind of prevention and treatment type II diabetes Phellinus is logical to rush down formula and preparation process | |
CN104083728A (en) | Processing method of anticancer and tumor eliminating concentrated pill | |
CN103340991B (en) | Oral liquid for nursing diabetics and preparation method thereof | |
CN113826882A (en) | Dietary nutrition supplement for preventing and treating diabetes and preparation process thereof | |
CN102988747B (en) | Aristida triseta electuary for reducing hypertension, hyperglycemia and hyperlipidemia and preparation method thereof | |
CN112402569A (en) | Anti-fatigue health product and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20190121 Address after: 518000, 1001, 10th floor, Jiaye Plaza, 2055 Bixin Road, Longgang Street, Longgang District, Shenzhen City, Guangdong Province Applicant after: Doctor Biotechnology (Shenzhen) Co., Ltd. Address before: 453634 Jitun Town, Huixian City, Xinxiang City, Henan Province Applicant before: Liu Deping |
|
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180914 |